biotechnolog
use
live
system
develop
product
plant
biotechnolog
gener
use
product
servic
eg
differ
bioactiv
secondari
metabolit
includ
alkaloid
flavonoid
phenol
saponin
terpenoid
steroid
glycosid
tannin
volatil
oil
etc
plant
cell
tissu
organ
cultur
independ
geograph
climat
factor
asept
condit
bioactiv
compound
econom
import
drug
pharmaceut
flavor
perfum
fragranc
pigment
dye
agrochem
well
cosmet
food
addit
etc
differ
strategi
eg
genet
transform
plant
agrobacterium
rhizogen
hairi
root
other
appli
improv
product
bioactiv
compound
secondari
metabol
origin
recombin
dna
techniqu
use
manipul
metabol
pathway
produc
protein
pharmaceut
antibodi
protein
hormon
bioinformat
genom
find
applic
drug
discoveri
plantbas
product
biotechnolog
procedur
enhanc
advanc
studi
medicin
plant
molecular
biotechnolog
use
laboratori
techniqu
studi
modifi
nucleic
acid
protein
applic
area
human
anim
health
agricultur
environ
herbal
extract
wide
use
manag
chronic
diseas
like
diabet
hypertens
cancer
etc
part
cam
therapi
plantderiv
immun
stimul
divers
small
larg
molecul
saponin
tomatin
inulin
polysaccharid
fungal
bglucan
complex
molecul
marin
spong
agalactosylceramid
shrimp
chitin
chitosan
etc
establish
adjuv
activ
immunotherapi
may
activ
immunotherapi
suppress
immunotherapi
vaccin
provid
immun
protect
diseas
plantbas
edibl
vaccin
product
mainli
involv
integr
transgen
plant
cell
produc
antigen
protein
specif
diseas
biotechnolog
biotech
use
live
system
organ
develop
make
use
product
technolog
applic
use
biolog
system
live
organ
deriv
thereof
make
modifi
product
process
specif
use
plant
biotechnolog
may
defin
gener
use
product
servic
plant
cell
tissu
often
organ
small
organ
explant
cell
tissu
organ
either
continu
maintain
vitro
pass
variabl
phase
enabl
regener
complet
plant
ultim
transfer
field
plant
synthes
larg
number
bioactiv
secondari
metabolit
includ
alkaloid
flavonoid
phenol
saponin
terpenoid
steroid
glycosid
tannin
volatil
oil
etc
applic
secondari
bioactiv
compound
fall
five
main
categori
viz
drug
pharmaceut
flavor
perfum
fragranc
pigment
dye
agrochem
well
cosmet
food
addit
etc
metabolit
obtain
plant
vitro
synthesi
compound
industri
level
difficult
due
complex
chemic
structur
complic
biosynthet
pathway
biotechnolog
offer
valuabl
tool
produc
compound
interest
desir
amount
ecofriendli
way
vitro
plant
cell
cultur
techniqu
plant
cell
tissu
organ
cultiv
asept
condit
independ
geograph
climat
factor
offer
altern
produc
import
metabolit
process
includ
mainli
four
main
approach
viz
callu
suspens
immobil
cell
differenti
cultur
callu
cultur
involv
grow
disorgan
aggreg
cell
plant
explant
cultur
semisolid
support
contain
nutrient
hormon
requir
promot
growth
cell
suspens
cultur
result
callu
suspend
liquid
growth
medium
grow
cell
dispers
cell
cultur
rel
fast
growth
suspens
cultur
wide
employ
studi
bioactiv
secondari
metabolit
product
plant
cell
advantag
approach
obviou
biomass
product
rapid
whole
plant
nutrit
environment
requir
easili
control
allow
product
pharmaceut
throughout
year
necessari
nutrient
uptak
enhanc
submerg
cultur
condit
stimul
multipl
rate
higher
yield
bioactiv
compound
sever
studi
vitro
cultur
found
effici
whole
plant
product
differ
bioactiv
secondari
metabolit
ie
level
product
ajmalicin
ajmalin
anthraquinon
benzylisoquinolin
alkaloid
berberin
bisoclaurin
coniferin
diosgenin
ginseng
ginsenosid
glutathion
nicotin
rosmarin
acid
raucaffricin
shikonin
taxol
terpentin
tripdiolid
etc
high
vitro
cultur
compar
whole
plant
product
follow
agronom
method
plant
cell
cultur
system
repres
potenti
renew
sourc
valuabl
medicin
compound
flavor
fragranc
color
produc
microbi
cell
chemic
synthesi
plant
tissu
cultur
technolog
could
potenti
altern
approach
bioproduct
phytoconstitu
therapeut
valu
might
attract
certain
condit
exampl
sourc
plant
difficult
cultiv
long
cultiv
period
low
metabolit
yield
chemic
synthesi
achiev
technic
problemat
vitro
cultur
plant
cell
tissu
organ
form
integr
part
plant
biotechnolog
activ
employ
biotechnolog
techniqu
possibl
regul
biosynthet
pathway
plant
order
enhancedecreas
synthesi
particular
compound
differ
strategi
also
appli
improv
product
bioactiv
compound
secondari
metabol
origin
major
obstacl
face
studi
medicin
plant
includ
inaccur
identif
speciat
low
yield
bioactiv
metabolit
variabl
tradit
protocol
etc
research
area
plant
tissu
organ
cultur
technolog
result
product
mani
bioactiv
metabolit
alkaloid
terpenoid
steroid
sterol
saponin
phenol
flavonoid
amino
acid
cphycocyanin
glycosid
etc
new
therapeut
defin
condit
bioactiv
compound
may
deriv
microbi
algal
veget
sourc
use
antioxid
antiinflammatori
agent
antiallergen
compound
etc
recent
develop
overcom
difficulti
aris
cell
suspens
cultur
genet
transform
plant
agrobacterium
rhizogen
hairi
root
found
suitabl
product
secondari
metabolit
stabl
high
product
hormonefre
cultur
condit
recombin
dna
techniqu
use
manipul
metabol
pathway
produc
protein
pharmaceut
antibodi
protein
hormon
new
disciplin
bioinformat
genom
find
applic
drug
discoveri
plantbas
product
biotechnolog
procedur
enhanc
advanc
studi
medicin
plant
planttransform
technolog
reach
platform
commerci
realiti
despit
advanc
biotechnolog
techniqu
success
exampl
secondari
compound
product
industri
level
biotechnolog
import
secondari
metabolit
lie
fact
mani
commerci
valuabl
chemic
ii
number
toxic
remov
food
product
iii
act
protect
agent
use
plant
insect
pathogen
anim
forag
variou
object
achievedachiev
plant
biotechnolog
may
summar
follow
use
biochem
product
largescal
cell
cultur
ii
rapid
clonal
multipl
adventiti
shootbulbprotocorm
iii
viru
elimin
thermo
cryo
chemotherapi
coupl
meristem
cultur
iv
rapid
develop
homozyg
line
produc
haploid
anther
cultur
ovari
cultur
interspecif
hybrid
v
productionrecoveri
difficult
produc
hybrid
embryo
rescu
vitro
pollin
vi
germplasm
conserv
veget
reproduc
plant
produc
recalcitr
seed
cryopreserv
slow
growth
cultur
dna
clone
vii
genet
modif
plant
somaclon
variat
somat
hybrid
cybrid
gene
transfer
viii
creation
genom
map
use
molecular
marker
assist
convent
breed
effort
plant
tremend
sourc
synthesi
bioactiv
secondari
metabolit
econom
import
drug
flavor
fragranc
dye
pigment
pesticid
food
addit
recent
advanc
molecular
biolog
enzymolog
ferment
technolog
suggest
plant
product
extract
asept
cultur
plant
cell
tissu
organ
base
biosynthet
origin
bioactiv
secondari
metabolit
plant
divid
three
major
group
phenol
compound
ii
terpenoid
iii
nitrogencontain
alkaloid
sulfurcontain
compound
compar
anoth
group
secondari
metabolit
phenol
compound
larg
respons
benefici
effect
human
health
natur
occur
compound
found
larg
fruit
veget
cereal
beverag
phenol
solubl
found
cell
wall
solubl
phenol
present
within
plant
cell
vacuol
phenol
classifi
differ
group
function
number
phenol
ring
structur
main
class
includ
phenol
acid
flavonoid
stilben
lignan
includ
apigenin
diosmin
quercetin
kaempferol
eriodictyol
naringenin
hesperetin
baicalein
chrysin
catechin
morin
genistein
curcumin
colchicin
resveratrol
emodin
etc
plant
cell
tissu
organ
cultur
establish
routin
work
steril
condit
explant
plant
leav
stem
root
meristem
etc
product
extract
hundr
bioactiv
secondari
metabolit
karuppusami
tabl
one
excit
aspect
cell
cultur
technolog
potenti
produc
novel
structur
observ
parent
plant
eg
rutacultin
cultur
ruta
graveolen
sesquiterpen
lacton
cultur
andrographi
paniculata
tabl
show
plant
sourc
differ
pharmaceut
valuabl
bioactiv
compound
use
plant
tissu
cultur
biotechnolog
product
bioactiv
phytoconstitu
commerci
scale
attract
sever
reason
tissu
cultur
protocol
develop
sever
plant
develop
mani
speci
refin
cultur
system
improv
biochem
yield
consider
half
dozen
cell
cultur
produc
biochem
molecular
biotechnolog
use
laboratori
techniqu
studi
modifi
nucleic
acid
protein
applic
area
human
anim
health
agricultur
environ
molecular
biotechnolog
result
converg
mani
area
research
molecular
biolog
microbiolog
biochemistri
immunolog
genet
cell
biolog
includ
techniqu
molecular
clone
polymeras
chain
reaction
gel
electrophoresi
macromolecul
blot
probe
microarray
allelespecif
oligonucleotid
high
throughput
screen
ht
techniqu
vitro
synthesi
bioactiv
molecul
etc
excit
field
fuel
abil
transfer
genet
inform
organ
goal
understand
import
biolog
process
creat
use
product
inform
human
genom
project
open
myriad
opportun
creat
new
medicin
treatment
well
approach
improv
exist
medicin
molecular
biotechnolog
rapidli
chang
dynam
field
import
impact
molecular
biotechnolog
felt
across
nation
molecular
biotechnolog
applic
plant
anim
agricultur
aquacultur
chemic
textil
manufactur
forestri
food
process
tool
molecular
biotechnolog
appli
develop
improv
drug
vaccin
therapi
diagnost
test
improv
human
anim
health
vitro
techniqu
plant
bioactiv
compound
product
plant
cell
tissu
organ
cultiv
asept
condit
independ
geograph
climat
factor
offer
altern
approach
produc
import
bioactiv
metabolit
face
differ
advers
circumst
circumst
loss
plant
popul
genet
divers
habitat
degrad
even
speci
extinct
etc
emerg
viabl
biotechnolog
tool
product
bioactiv
compound
use
diversifi
area
particularli
view
addit
effort
sustain
conserv
ration
util
biodivers
plant
tissu
cultur
technolog
could
potenti
altern
approach
product
highvalu
bioactiv
phytoconstitu
therapeut
import
might
attract
certain
condit
sourc
plant
difficult
cultiv
ii
long
cultiv
period
iii
low
metabolit
yield
iv
chemic
synthesi
achiev
due
technic
problem
etc
addit
v
novel
compound
gener
found
parent
plant
produc
vitro
grown
plant
plant
tissu
cultur
well
vi
stereoand
regionspecif
biotransform
plant
cell
perform
product
bioactiv
compound
econom
precursor
increas
demand
market
novel
product
deriv
plant
vitro
cultur
becom
reliabl
techniqu
mass
product
plant
materi
number
advantag
use
plant
cell
cultur
provid
impetu
use
largescal
product
import
bioactiv
compound
industri
level
advantag
summar
follow
plant
cell
cultur
independ
environment
factor
ii
product
level
may
gear
accur
accord
market
demand
iii
use
character
cell
line
consist
product
qualiti
yield
maintain
iv
new
rout
synthesi
recov
mutant
cell
line
may
lead
develop
novel
product
v
cultur
cell
reduc
pressur
alreadi
overexploit
medicin
econom
import
plant
vi
advantag
method
ultim
provid
continu
reliabl
sourc
natur
product
vii
advantag
cell
cultur
includ
synthesi
bioactiv
secondari
metabolit
run
control
environ
independ
climat
soil
condit
viii
use
vitro
plant
cell
cultur
product
chemic
pharmaceut
made
great
stride
build
advanc
plant
scienc
ix
increas
use
genet
tool
emerg
pictur
structur
regul
pathway
secondari
metabol
provid
basi
product
commerci
accept
level
product
x
increas
level
natur
product
medicin
purpos
coupl
low
product
yield
suppli
concern
plant
harvest
renew
interest
largescal
plant
cell
cultur
technolog
xi
knowledg
biosynthet
pathway
desir
phytochem
plant
well
cultur
often
still
infanc
consequ
strategi
need
develop
inform
base
cellular
molecular
level
result
show
vitro
plant
cell
cultur
potenti
commerci
product
secondari
metabolit
xii
introduct
newer
techniqu
molecular
biolog
produc
transgen
cultur
effect
express
regul
biosynthet
pathway
also
like
signific
step
toward
make
cell
cultur
gener
applic
commerci
product
secondari
metabolit
medicin
plant
play
import
role
prevent
treat
human
diseas
bioactiv
phytochem
present
play
import
role
health
promot
diseas
prevent
cur
efficaci
medicin
plant
due
bioactiv
metabolit
pharmacolog
activ
compound
eg
alkaloid
antispasmod
antimalari
analges
diuret
activ
phenol
flavonoid
antioxid
antiallergen
antibacteri
properti
terpenoid
known
antivir
anthelmint
antibacteri
anticanc
antimalari
antiinflammatori
properti
glycosid
report
antifung
antibacteri
properti
saponin
report
antiinflammatori
antivir
plant
defens
activ
use
medicin
herb
herbal
prepar
ageold
tradit
recent
progress
modern
therapeut
stimul
use
natur
therapeut
prevent
treatment
differ
diseas
differ
bioactiv
compound
differ
plant
sourc
found
effect
vast
array
diseas
eg
taxol
taxu
brevifolia
vinblastin
vincristin
catharanthu
roseu
topotecan
irinotecan
camptotheca
acumin
etoposid
teniposid
podophyllum
peltatum
show
antitumor
anticanc
activ
curcumin
curcuma
longa
show
anticanc
antiinflammatori
hepatoprotect
flavonoid
silymarin
silibinin
silybum
marianum
show
anticanc
antiinflammatori
liver
tonic
hepat
disord
properti
ricinin
lectin
ricin
ricinu
communi
show
hepatoprotect
antioxid
hypoglycem
antitumor
activ
tannin
shikim
acid
compound
triterpenoid
ellag
acid
terminalia
chebula
show
antioxid
antidiabet
renoprotect
hepatoprotect
activ
steroid
lacton
withanolid
notabl
withaferin
withania
somnifera
show
chemoprevent
anticancer
memori
enhanc
immunomodulatori
properti
use
parkinson
alzheim
disord
mono
sesquiterpenoid
zingeron
gingerol
zinzib
officinali
anticanc
antioxid
hepatoprotect
hypercholesterolaem
antiatherosclerot
limonoid
nimbidinin
diand
triterpenoid
azadirachta
indica
function
inhibitor
carcinoma
chemoprevent
inhibit
colon
cancer
antiallerg
blood
purifi
piperidin
dehydropipernonalin
piper
nigrum
anticarcinogen
antihyperlipidaem
use
epilepsi
diterpenoid
furanolacton
tinosporin
isoquinolin
alkaloid
tinospora
cordifolia
function
immunomodul
chemoprevent
cardioprotect
antidiabet
agent
aloin
emodin
campesterol
bsisosterol
alo
vera
show
heal
properti
antivir
antitumor
activ
antidiabet
hepatoprotect
antisept
effect
apigenin
taxol
ursol
acid
citral
ocimum
sanctum
show
antidiabet
hepatoprotect
antibacteri
antifung
antipyret
anticanc
properti
berberin
berberi
vulgari
work
antidiabet
hepatoprotect
antimicrobi
digoxin
digitali
lanata
use
heart
diseas
thymoquinon
nigella
sativa
show
antidiabet
anticanc
antimicrobi
hepatoren
protect
gastroprotect
quinq
quinin
cinchona
robusta
show
antimalari
antiparasit
effect
artemisinin
artemisia
absinthium
antimaleri
drug
ophel
acid
sawertiamarin
mangeferin
amarogenitin
swertia
chirata
show
antidiabet
antivir
hepatoren
protect
activ
allicin
allium
sativum
cardioprotect
antiinflammatori
arjun
acid
tannic
acid
tannin
saponin
gallic
acid
phytosterol
terminalia
arjuna
cardioprotect
anticanc
agent
hepatoprotect
emblicanin
emblicanin
b
punigluconin
pedunculagin
phyllanthu
emblica
antivir
antimicrobi
anticanc
hepatoprotect
antidiabet
ajmalicin
reserpin
rauvolfia
serpentin
show
hypotens
properti
phenol
compound
gynura
procumben
antidiabet
etc
herbal
medicin
prefer
way
complementari
altern
medicin
cam
use
world
manag
differ
chronic
diseas
diabet
mellitu
dm
hypertens
ht
hyperlipidemia
hl
etc
among
other
preval
chronic
diseas
world
lead
chronic
diseas
includ
osteoporosi
cardiovascular
diseas
heart
attack
stroke
ischem
cardiopathi
chronic
obstruct
pulmonari
diseas
copd
asthma
epilepsi
seizur
obes
oral
health
problem
hepat
c
hiv
aid
dementia
alzheim
autoimmun
parkinson
diseas
schizophrenia
bipolar
disord
multipl
sclerosi
glaucoma
etc
patient
chronic
diseas
frequent
occasion
use
herbal
medicin
includ
cam
world
treatment
divers
low
cost
safeti
work
total
patient
male
femal
year
mean
age
particip
tulunay
et
al
note
patient
use
herbal
medicin
use
use
among
femal
gender
significantli
higher
p
convent
medic
use
found
lower
among
herbal
medicin
consum
frequent
use
herb
lemon
garlic
ht
cinnamon
dm
walnut
hl
number
photochem
nutraceut
eg
acid
dietari
fiber
vitamin
antioxid
plant
sterol
flavonoid
medicin
plant
benefici
effect
chronic
diseas
nutraceut
photochem
without
side
effect
less
cost
also
abund
help
prevent
number
chronic
diseas
act
chronic
fighter
diabet
mellitu
dm
confus
diabet
insipidu
di
diabet
insipidu
occur
person
kidney
pass
abnorm
larg
volum
urin
insipid
dilut
odorless
peopl
kidney
pass
quart
urin
day
person
di
kidney
pass
quart
urin
day
result
person
di
may
feel
need
drink
larg
amount
liquid
dm
result
insulin
defici
resist
lead
high
blood
glucos
also
call
blood
sugar
diabet
insipidu
diabet
mellitu
unrel
although
condit
caus
frequent
urin
constant
thirst
diabet
mellitu
caus
high
blood
glucos
blood
sugar
result
bodi
inabl
use
blood
glucos
energi
peopl
diabet
insipidu
normal
blood
glucos
level
howev
kidney
balanc
fluid
bodi
excess
urin
extrem
thirst
result
inadequ
output
pituitari
hormon
adh
antidiuret
hormon
vasopressin
fig
lack
normal
respons
kidney
adh
four
type
diabet
insipidu
central
diabet
insipidu
ii
nephrogen
diabet
insipidu
iii
dipsogen
diabet
insipidu
iv
gestat
diabet
insipidu
common
symptom
di
frequent
urin
rare
disord
ie
rare
diseas
caus
frequent
urin
diabet
mellitu
dm
one
common
seriou
chronic
diseas
worldwid
dm
chronic
endocrin
disord
involv
common
metabol
disord
carbohydr
fat
protein
group
noncommunic
diseas
ncd
dm
character
elev
plasma
glucos
concentr
result
insuffici
insulin
call
insulindepend
diabet
mellitu
iddm
juvenileon
set
diabet
type
diabet
call
noninsulindepend
diabet
mellitu
niddm
adultonset
diabet
nation
institut
clinic
excel
nice
recommend
target
blood
glucos
level
rang
normal
diabet
blood
sugar
major
healthi
individu
normal
blood
sugar
level
follow
nice
diabetesco
uk
http
wwwdiabetescoukdiabetescarebloodsugarlevelrang
mmoll
mgdl
fast
ii
mmoll
mgdl
h
eat
peopl
diabet
blood
sugar
level
target
follow
iii
meal
mmoll
peopl
type
type
diabet
iv
meal
mmoll
peopl
type
diabet
mmoll
peopl
type
diabet
tabl
summar
data
random
plasma
glucos
test
blood
sampl
random
plasma
glucos
test
taken
time
requir
much
plan
therefor
use
diagnosi
type
diabet
time
essenc
fast
plasma
glucos
test
fast
plasma
glucos
test
taken
least
h
fast
therefor
usual
taken
morn
nice
guidelin
regard
fast
plasma
glucos
result
mmoll
put
someon
higher
risk
develop
type
diabet
particularli
accompani
risk
factor
type
diabet
oral
glucos
toler
test
ogtt
oral
glucos
toler
test
involv
first
take
fast
sampl
blood
take
sweet
drink
contain
g
glucos
drink
need
stay
rest
blood
sampl
taken
h
test
diabet
diagnosi
test
directli
measur
level
blood
glucos
howev
result
test
influenc
high
low
blood
glucos
level
tend
period
month
nondiabet
mmoll
mmoll
type
diabet
mmoll
mmoll
type
diabet
mmoll
mmoll
mmoll
children
wtype
diabet
mmoll
mmoll
mmoll
nondiabet
figur
provid
inform
part
nice
guidelin
indic
diabet
prediabet
given
follow
condit
normal
mmolmol
ii
prediabet
mmolmol
iii
diabet
mmolmol
comprehens
herbal
drug
therapeut
regimen
offer
timetest
safe
effect
support
convent
therapi
manag
diabet
combin
adequ
dietari
manag
physic
activ
would
provid
integr
approach
manag
deadli
diseas
particularli
type
diabet
develop
type
diabet
link
bcell
failur
coupl
insulin
resist
obes
adipos
tissu
known
fat
store
secret
number
hormon
protein
collect
term
adipokin
regul
insulin
sensit
diabet
metabol
endocrin
disord
character
hyperglycemia
glucos
intoler
due
insulin
resist
research
confirm
inflamm
close
involv
pathogenesi
diabet
complic
herbal
medic
long
use
treatment
prevent
tradit
chines
medicin
tcm
tradit
indian
medicin
ayurveda
unani
exist
therapeut
drug
use
diabet
increas
variou
secondari
complic
includ
cardiovascular
diseas
kidney
failur
liver
injuri
dizzi
mental
disord
weight
gain
skin
diseas
nowaday
key
therapeut
agent
treat
complic
sulfonylurea
metformin
insulinsensit
glitazon
improv
metabol
control
lead
control
variou
circul
inflamm
mediat
innat
immunityrel
signal
pathway
sulfonylurea
metformin
main
drug
prevent
sulfonylurea
increas
insulin
product
pancreat
bcell
metformin
suppress
glucos
product
liver
meanwhil
increas
insulin
sensit
peripher
tissu
glitazon
anoth
antidiabet
drug
bind
peroxisom
proliferatoractiv
receptor
ppar
begin
transcript
activ
lead
improv
insulin
action
reduc
secret
inflammatori
marker
consequ
glitazon
reduc
level
crp
tnfa
inflammatori
marker
drug
show
better
antidiabet
natur
also
compar
antiinflammatori
potenti
therapeut
approach
would
act
princip
inflammatori
system
propos
form
salicyl
antiinflammatori
therapeut
inhibit
ijb
kinas
ikk
also
lower
glucos
level
improv
beta
cell
function
variou
wellestablish
nonsteroid
antiinflammatori
drug
nsaid
cyclooxygenas
inhibitor
eg
ibuprofen
naproxen
abl
improv
glucosemedi
macrosomia
research
search
effici
natur
therapeut
target
less
side
effect
natur
productsderiv
bioactiv
molecul
improv
insulin
resist
associ
complic
suppress
inflammatori
signal
pathway
huge
number
activ
medicin
plant
natur
bioactiv
molecul
alreadi
report
therapeut
natur
diabet
sever
medicin
plant
use
sinc
ancient
time
manag
prevent
diabet
associ
condit
tabl
part
antidiabet
plant
equal
import
prepar
hypoglycem
extract
differ
part
includ
whole
plant
leaf
root
rhizom
flower
fruit
seed
etc
antidiabet
plant
use
desir
hypoglycem
activ
shown
tabl
differ
bioactiv
phytoconstitu
follow
similar
differ
way
allevi
hyperglycem
activ
alkaloid
inhibit
alpha
glucosidas
decreas
glucos
transport
intestin
epithelium
eg
berberin
root
stem
bark
berberi
spp
cordifolia
casuarin
bark
syzygium
malaccens
catharanthin
vindolin
vindolin
leaf
stem
c
roseu
calystegin
fruit
nicandra
physalod
cryptolepin
cryptolepi
sanguinolenta
harman
norharman
tribulu
terrestri
jambosin
bark
seed
fruit
syzygium
cumini
jatrorrhizin
magnoflorin
palmatin
cordifolia
javaberin
javaberin
hexaacet
javaberin
b
hexaacet
root
talinum
paniculatum
lepidin
semilepidin
seed
lepidium
sativum
lupanin
lupinu
perenni
mahanimbin
leaf
murraya
koenigii
piperumbellactam
branch
piper
umbellatum
radicamin
b
lobelia
chinensi
swerchirin
chirayita
tecomin
tecoma
stan
trigonellin
seed
trigonella
foenumgraecum
leaf
bark
moru
alba
ii
imidazolin
compoundsstimul
insulin
secret
glucosedepend
manner
insulinotrop
eg
imidazolin
found
increas
basaland
glucosestimul
insulin
releas
vitro
vivo
iii
polysaccharid
increas
level
serum
insulin
reduc
blood
glucos
level
improv
toler
glucos
polysaccharid
like
bellidifolin
swertia
japonica
bakuchiol
otholobium
pubescen
curcuminoid
rhizom
c
longa
ellagitannin
fruit
chebula
tabl
bioactiv
compound
insulin
secretagogu
insulin
mimet
activ
howev
may
differ
differ
plant
tabl
structur
phytoconstitu
hypoglycem
activ
given
fig
medicin
plant
bioactiv
compound
extract
show
glucoselow
either
insulinmimick
activ
enhanc
bcell
regener
glucos
uptak
phytoconstitu
like
alkaloid
major
role
alkaloid
inhibit
alphaglucosidas
decreas
glucos
transport
intestin
epithelium
imidazolin
compound
stimul
insulin
secret
glucosedepend
manner
polysaccharid
increas
level
serum
insulin
reduc
blood
glucos
level
serum
insulin
reduc
blood
glucos
level
enhanc
toler
glucos
flavonoid
suppress
glucos
level
saponin
stimul
releas
insulin
block
format
glucos
bloodstream
bhushan
et
al
antidiabet
principl
bitter
melon
mixtur
steroid
saponin
insulinlik
peptid
alkaloid
triterpenoid
alkaloid
aconitin
anisodamin
charantin
leurosin
show
antidiabet
effect
dietari
flavonoid
acarbos
synergist
inhibit
aglucosidas
lower
postprandi
blood
glucos
hypertens
htn
high
blood
pressur
bp
chronic
medic
condit
bp
arteri
elev
bp
combin
systol
diastol
pressur
accord
criteria
hypertens
mean
elev
blood
pressur
level
mmhg
lifton
systol
pressur
repres
blood
forc
pressur
heart
beat
diastol
pressur
stand
blood
pressur
heart
rest
systol
pressur
alway
first
top
measur
blood
pressur
read
read
repres
systol
pressur
repres
diastol
pressur
prehypertens
systol
number
rang
diastol
number
less
htn
name
silent
killer
asymptomat
major
contributor
risk
factor
cardiovascular
morbid
mortal
gavra
systol
diastol
iv
stage
high
blood
pressur
systol
least
diastol
least
mmhg
accord
barker
et
al
categori
hypertens
adult
may
differ
tabl
although
number
systol
diastol
read
signific
age
systol
number
import
high
blood
pressur
case
due
secondari
identifi
caus
medic
condit
diseas
organ
high
blood
pressur
happen
pressur
arteri
blood
vessel
becom
high
arteri
wall
becom
distort
caus
extra
stress
heart
longterm
high
blood
pressur
increas
risk
stroke
heart
attack
diabet
result
high
blood
pressur
includ
arteri
damag
aneurysm
heart
failur
block
ruptur
blood
tabl
differ
caus
hypertens
describ
tabl
recent
evid
indic
hypertens
rais
blood
pressur
increas
partli
increas
risk
factor
includ
smoke
obes
high
use
alcohol
social
insecur
anxieti
lack
exercis
dietari
lifestyl
chang
well
medicin
improv
bp
control
decreas
risk
associ
health
complic
convent
antihypertens
usual
associ
mani
side
effect
convent
medicin
use
treatment
hypertens
classifi
follow
diureticsdiuret
help
kidney
elimin
excess
salt
water
bodi
tissu
blood
includ
loop
diuret
bumetanid
ethacryn
acid
furosemid
torsemid
thiazid
diuret
epitizid
hydrochlorothiazid
chlorothiazid
bendroflumethiazid
methyclothiazid
polythiazid
thiazidelik
diuret
indapamid
chlorthalidon
metolazon
potassiumspart
diuret
amilorid
triamteren
spironolacton
eplerenon
ii
adrenerg
receptor
antagonistsbeta
blocker
atenolol
bisoprolol
betaxolol
carteolol
carvedilol
labetalol
metoprolol
nadolol
nebivolol
oxprenolol
penbutolol
pindolol
propranolol
timolol
etc
alpha
blocker
doxazosin
phentolamin
indoramin
phenoxybenzamin
prazosin
barker
et
al
terazosin
tolazolin
mix
alpha
beta
blocker
bucindolol
carvedilol
labetalol
iii
adrenerg
receptor
agonistscentr
act
adrenerg
drug
adrenerg
receptor
agonistclonidin
guanabenz
guanfacin
methyldopa
moxonidin
iv
calcium
channel
blockerscalcium
channel
blocker
block
entri
calcium
muscl
cell
arteri
wall
includ
dihydropyridin
amlodipin
lacidipin
cilnidipin
clevidipin
felodipin
isradipin
lercanidipin
levamlodipin
nicardipin
nifedipin
nimodipin
nisoldipin
nitrendipin
nondihydropyridin
diltiazem
verapamil
v
ace
inhibitorsac
inhibitor
inhibit
activ
angiotensinconvert
enzym
ace
enzym
respons
convers
angiotensin
angiotensin
ii
potent
vasoconstrictor
exampl
includ
captopril
enalapril
fosinopril
lisinopril
moexipril
perindopril
quinapril
ramipril
trandolapril
benazepril
etc
mani
antihypertens
agent
side
effect
eg
diuret
may
caus
muscl
cramp
dizzi
extrem
tired
dehydr
blur
vision
abnorm
heart
rate
skin
rash
other
ace
inhibitor
may
caus
cough
skin
rash
vomit
kidney
failur
fever
sore
throat
diarrhea
other
side
effect
come
use
calcium
channel
blocker
fatigu
headach
diarrhea
constip
skin
rash
edema
etc
herb
caus
side
effect
like
weak
tired
drowsi
impot
cold
hand
feet
depress
insomnia
abnorm
heartbeat
skin
rash
dri
mouth
dri
cough
stuffi
nose
headach
dizzi
swell
around
eye
constip
diarrhea
fever
etc
herbal
medicin
gain
attent
treatment
hypertens
develop
develop
countri
wide
biolog
medicin
activ
divers
eas
avail
higher
safeti
margin
low
cost
novel
pharmaceut
past
decad
lot
concert
effort
channel
research
local
plant
forskolin
steviosid
diterpenoid
glycosid
dda
diterpenoid
acid
acid
two
kauranetyp
diterpen
essenti
oil
constitu
apinen
aterpinen
cterpinen
pcymen
carvacrol
thymol
linalool
coumarin
praeruptorin
coumarin
imperatorin
dietari
furanocoumarin
ostruthol
furanocoumarin
flavonoid
quercetin
isorhamnetin
astragalin
orientin
cardamonin
alpinetin
flavonoid
butin
xjp
iv
phenol
glycosid
v
flavonoid
quercetin
isorhamnetin
stragalin
orientin
cardamonin
alpinetin
butin
vi
coumarin
praeruptorin
imperatorin
ostruthol
vii
diterpen
terpenoid
forskolin
steviosid
major
constitu
essenti
oilapinen
aterpinen
cterpinen
pcymen
carvacrol
thymol
linalool
viii
anthraquinon
ix
tannin
x
phytosterol
xi
cardiac
glycosid
xii
peptid
heshiko
xiii
othersdaleformi
ursol
moron
acid
magnesium
lithosperm
b
import
group
bioactiv
compound
play
domin
role
treatment
hypertens
structur
bioactiv
antihypertens
compound
shown
fig
cancer
class
diseas
character
outofcontrol
cell
growth
cancer
uncontrol
growth
abnorm
cell
bodi
cancer
develop
bodi
normal
control
mechan
stop
work
old
cell
die
instead
grow
control
form
new
abnorm
cell
extra
cell
may
form
mass
tissu
call
tumor
cancer
leukemia
form
tumor
differ
type
cancer
classifi
type
cell
initi
affect
cancer
respond
treatment
differ
way
type
cancer
best
treat
surgeri
other
respond
better
drug
chemotherapi
radiat
etc
often
treatment
use
get
best
result
cancer
divid
five
stage
use
intern
tnm
ii
iii
iv
stand
primari
tumor
n
lymph
node
distant
metastas
stage
mean
presenc
small
carcinoma
situ
spread
stage
iv
mean
cancer
spread
wide
cancer
metastas
case
stage
subclass
spread
primari
site
via
bloodstream
lymphat
system
organ
cancer
start
produc
metastas
becom
attach
organ
begin
divid
invad
space
differ
cancer
typic
metastas
certain
organ
eg
liver
lung
adren
gland
brain
bone
symptom
caus
metastas
vari
accord
locat
medicin
plant
use
prevent
treat
variou
diseas
compris
sourc
bioactiv
pharmaceut
benefici
health
effect
certain
bioactiv
compon
plant
confirm
anticanc
activ
includ
curcumin
turmer
genistein
soybean
egcg
green
tea
polyphenol
green
tea
resveratrol
grape
sulforaphan
broccoli
isothiocyan
crucifer
veget
silymarin
milk
thistl
diallyl
sulfid
garlic
lycopen
tomato
rosmarin
acid
rosemari
apigenin
parsley
gingerol
ginger
vitamin
e
plant
oil
boronrich
natur
compound
hydroxytyrosol
virgin
oliv
oil
phytoestrogen
etc
cancer
remain
one
lead
caus
death
world
modern
drugtarget
therapi
undeni
improv
cancer
patient
care
advanc
metastas
cancer
remain
untreat
cancer
chemoprevent
natur
bioactiv
phytochem
emerg
strategi
prevent
imped
delay
cure
cancer
apigenin
flavon
present
veget
parsley
celeri
chamomil
moringa
peregrina
demonstr
cytotox
activ
breast
cancer
cell
line
mcf
colon
cell
line
hct
cytotox
activ
compar
doxorubicin
ii
curcumin
diferuloylmethan
major
compon
popular
spice
turmer
c
longa
l
member
ginger
famili
anticanc
effect
studi
colon
cancer
breast
cancer
lung
metastas
brain
tumor
iii
crocetin
crocu
sativu
l
saffron
food
color
present
dri
stigma
plant
potenti
agent
novel
anticanc
drug
hepatocellular
carcinoma
iv
cyanidin
extract
pigment
red
berri
grape
blackberri
cranberri
raspberri
appl
plum
red
cabbag
red
onion
possess
antioxid
radicalscaveng
effect
may
reduc
risk
cancer
v
found
brassica
veget
broccoli
cauliflow
collard
green
diindolylmethan
dim
digest
deriv
via
condens
form
acid
environ
stomach
studi
anticarcinogen
effect
vi
epigallocatechin
gallat
egcg
abund
catechin
compound
green
tea
egcg
benefici
treat
brain
prostat
cervic
bladder
cancer
vii
fisetin
flavon
found
variou
plant
acacia
greggii
acacia
berlandieri
eurasian
smoketre
parrot
tree
strawberri
appl
persimmon
grape
onion
cucumb
fisetin
allevi
age
effect
yeast
fruit
fli
exert
antiinflammatori
effect
lpsinduc
acut
pulmonari
inflamm
anticarcinogen
effect
human
colon
cancer
cell
viii
genistein
isoflavon
origin
number
plant
lupin
fava
bean
soybean
kudzu
psoralea
coffe
function
antioxid
anthelmint
genistein
found
antiangiogen
effect
block
format
new
blood
vessel
may
block
uncontrol
cell
growth
associ
cancer
like
inhibit
enzym
regul
cell
divis
cell
surviv
growth
factor
ix
gingerol
activ
compon
fresh
ginger
distinct
spicy
gingerol
studi
anticancer
effect
tumor
colon
breast
ovarian
pancrea
x
kaempferol
natur
flavonol
isol
tea
broccoli
witchhazel
grapefruit
brussel
sprout
appl
etc
studi
pancreat
cancer
lung
cancer
xi
lycopen
bright
red
pigment
phytochem
tomato
red
carrot
watermelon
red
papaya
demonstr
antioxid
activ
chemoprevent
effect
mani
studi
especi
prostat
cancer
xii
phenyl
isothiocyan
peitc
along
sulforaphan
crucifer
veget
watercress
broccoli
cabbag
etc
studi
induct
apoptosi
cell
line
peitc
shown
strong
potenc
melanoma
intens
studi
chemoprevent
breast
cancer
cell
nonsmallcel
lung
cancer
cervic
cancer
osteogen
sarcoma
os
prostat
cancer
myeloma
cell
line
xiii
resveratrol
natur
phenol
found
red
grape
skin
peanut
fruit
cancer
chemoprevent
xiv
rosmarin
acid
ra
natur
antioxid
found
culinari
spice
medicin
herb
lemon
balm
peppermint
sage
thyme
oregano
rosemari
treat
numer
ailment
rosemari
extract
play
import
role
antiinflamm
antitumor
antiprolifer
variou
vitro
vivo
studi
xv
sulforaphan
organosulfur
compound
obtain
crucifer
veget
broccoli
brussel
sprout
cabbag
enzym
myrosinas
gi
tract
transform
glucoraphanin
sulforaphan
upon
damag
plant
chew
xvi
triterpenoid
biosynthes
plant
cycliz
squalen
triterpen
hydrocarbon
precursor
steroid
group
phytochem
subclassifi
cucurbitan
dammaran
ergostan
friedelan
lanostan
limonoid
lupan
oleanan
tirucallan
ursan
list
still
grow
variou
vitro
vivo
studi
conduct
chemoprevent
therapi
breast
cancer
pancreat
cancer
use
triterpenoid
xvii
lightexpos
mushroom
could
excel
sourc
vitamin
vitamin
involv
breast
cancer
colon
cancer
ovarian
cancer
pancreat
cancer
xviii
vitamin
e
includ
tocopherol
tocotrienol
fatsolubl
antioxid
exist
mani
food
includ
wheat
germ
oil
sunflow
oil
safflow
oil
alphatocopherol
bioactiv
form
vitamin
e
stop
product
reactiv
oxygen
speci
ro
fat
undergo
oxid
report
tocopherol
tocotrienol
antitumor
effect
due
antioxid
properti
tocotrienol
show
stronger
bioactiv
show
antiprolif
proapoptot
inhibit
effect
vitro
studi
plantderiv
compound
import
sourc
sever
clinic
use
anticanc
agent
cragg
newman
includ
vinblastin
vincristin
camptothecin
deriv
topotecan
irinotecan
etoposid
deriv
epipodophyllotoxin
paclitaxel
taxol
number
promis
new
agent
clinic
develop
base
select
activ
cancerrel
molecular
target
includ
flavopiridol
combretastatin
phosphat
bioactiv
compound
fail
earlier
clinic
studi
stimul
renew
interest
differ
bioactiv
compound
respond
differ
differ
type
cancer
tabl
mechan
action
plantderiv
anticanc
drug
numer
induc
apoptot
cell
death
chemotherapi
treatment
cancer
cell
one
antineoplast
cytotox
agent
inhibitor
antimitot
antimicrotubul
mainli
target
rapidli
prolifer
cancer
cell
lead
induct
cell
death
figur
show
structur
bioactiv
herbal
anticanc
agent
camptothecin
cpt
topoisomeras
inhibitor
isol
bark
stem
camptotheca
acuminata
vinca
alkaloid
set
antimitot
antimicrotubul
alkaloid
agent
origin
deriv
periwinkl
plant
c
roseu
includ
vinblastin
vincristin
vindesin
vinorelbin
addit
research
vinca
alkaloid
includ
vinca
minor
vincristin
vinburnin
podophyllotoxin
ppt
nonalkaloid
toxin
lignan
extract
root
rhizom
found
p
peltatum
brevifolia
pacif
yew
use
basi
two
chemotherapi
drug
docetaxel
paclitaxel
ingenol
mebut
substanc
found
sap
plant
euphorbia
peplu
induc
cell
death
trastuzumab
emtansin
kadcyla
antibodi
conjug
synthet
deriv
cytotox
principl
ethiopian
plant
maytenu
ovatu
use
treat
breast
cancer
virus
acellular
particul
matter
made
nucleic
acid
protein
caus
mani
infecti
viral
diseas
includ
hiv
influenza
herp
simplex
viru
hsv
dengu
chikungunya
zika
hepat
hsv
hepat
b
hsb
hepat
c
hcv
etc
recent
outbreak
advent
global
eas
travel
underscor
prevent
critic
issu
safeguard
public
health
despit
progress
made
immun
drug
develop
mani
virus
lack
prevent
vaccin
effici
antivir
therapi
often
beset
gener
viral
escap
mutant
viral
diseas
pose
great
risk
human
health
viral
infect
tough
control
due
mut
natur
viral
genom
medicin
plant
provid
divers
bioactiv
phytochem
play
synerget
role
maintain
human
health
constant
emerg
new
resist
viral
strain
demand
novel
antivir
agent
fewer
side
effect
cell
toxic
kapoor
et
al
identifi
novel
antivir
drug
critic
import
natur
product
excel
sourc
surfac
target
cell
entri
uncoat
viru
particl
host
cell
replic
assembl
releas
adsorpt
viru
surfac
target
cell
may
inhibit
phytomolecul
pterocarnin
saikosaponin
glycyrrhiz
acid
replic
process
may
inhibit
phytomolecul
oxyresveratrol
polymethoxyl
flavonoid
jatrophan
ester
quercetin
deriv
antivir
bioactiv
compound
medicin
plant
name
chemic
class
activ
structur
given
tabl
fig
baicalin
flavon
glycosid
glucuronid
baicalein
found
sever
speci
genu
scutellaria
includ
scutellaria
baicalensi
scutellaria
lateriflora
chalcon
aromat
keton
enon
form
central
core
varieti
import
biolog
compound
known
collect
chalcon
chalconoid
honokiol
lignan
isol
bark
seed
cone
leav
tree
belong
genu
magnolia
medicin
plant
wide
use
worldwid
address
varieti
diseas
prevent
treatment
diseas
prevent
categor
three
level
primari
prevent
intend
decreas
number
new
case
disord
ill
health
promotioneduc
immun
ii
secondari
prevent
intend
lower
rate
establish
case
preval
ill
screen
prompt
manag
iii
tertiari
prevent
intend
decreas
amount
disabl
associ
exist
disord
rehabilit
mean
diseas
prevent
focus
strategi
reduc
risk
diseas
identifi
risk
factor
detect
diseas
earli
treatabl
stage
exampl
diseas
prevent
activ
includ
regular
health
examin
immun
calcium
vitamin
supplement
reduc
risk
osteoporosi
blood
pressur
assess
cholesterol
screen
ill
breast
cervic
colorect
prostat
cancer
medicin
plant
play
vital
role
diseas
prevent
promot
use
fit
exist
prevent
strategi
sofowora
et
al
provid
list
plant
potenti
prevent
medicin
practic
prevent
better
cure
doubt
golden
rule
health
manag
today
clear
need
prevent
diseas
develop
first
place
herbal
immunotherapi
may
help
regard
reach
desir
goal
immunopotenti
may
deriv
differ
natur
sourc
plant
fungi
marin
organ
other
plantderiv
immun
stimul
consist
divers
rang
small
molecul
larg
polysaccharid
eg
saponin
tomatin
inulin
etc
fungi
produc
rang
potenti
candid
molecul
eg
bglucan
complex
molecul
establish
adjuv
activ
includ
agalactosylceramid
marin
spong
chitosan
shrimp
chitin
peptid
bee
venom
organ
like
endophyt
fungi
bee
produc
immunostimul
use
compound
obtain
plant
wood
et
al
prevent
better
cure
proverb
impli
unwis
becom
diseas
go
treatment
get
rid
curs
impos
diseas
rather
diseas
prevent
attack
alway
safe
prevent
enemi
attack
boost
immun
system
prohibit
entri
microorgan
better
act
upon
later
immunotherapi
medic
term
defin
treatment
diseas
induc
enhanc
suppress
immun
respons
immunotherapi
design
elicit
amplifi
immun
respons
classifi
activ
immunotherapi
immunotherapi
reduc
suppress
classifi
suppress
immunotherapi
activ
agent
immunotherapi
collect
call
immunomodul
compris
divers
array
recombin
synthet
natur
prepar
often
cytokin
tabl
substanc
granulocyt
colonystimul
factor
gcsf
interferon
imiquimod
cellular
membran
fraction
bacteria
alreadi
licens
use
patient
other
includ
variou
chemokin
synthet
cytosin
phosphateguanosin
cpg
oligodeoxynucleotid
glucan
current
investig
extens
clinic
preclin
studi
immunomodulatori
regimen
offer
attract
approach
often
fewer
side
effect
exist
drug
includ
less
potenti
creat
resist
microbi
diseas
cellbas
immunotherapi
proven
effect
cancer
immun
effector
cell
lymphocyt
macrophag
dendrit
cell
natur
killer
cell
nk
cell
cytotox
tlymphocyt
ctl
etc
work
togeth
defend
bodi
cancer
target
abnorm
antigen
express
surfac
tumor
due
mutat
immun
booster
stimul
immun
system
intak
vaccin
toxoid
eg
detoxifi
bacteri
product
keep
antigen
properti
readi
use
antibodi
immunoglobulin
natur
activ
bodi
immun
booster
occur
result
infect
natur
passiv
immun
booster
occur
result
matern
antibodi
transport
placenta
fetu
newborn
bodi
witch
milk
case
manmad
passiv
immun
antibodi
insert
bodi
vaccin
detoxifi
bacteri
product
protect
bodi
long
time
sometim
till
one
die
day
readi
use
antibodi
provid
temporari
protect
administ
case
reinfect
two
way
manmad
activ
immun
booster
viz
intak
live
attenu
weaken
microorgan
ii
intak
kill
microorgan
toxin
antigen
case
person
get
vaccin
toxin
caus
diseas
stimul
immun
system
make
abl
recogn
attack
particular
microorgan
gener
vaccin
administ
parenter
inject
except
live
polio
vaccin
administ
oral
mouth
possibl
use
aerosol
vaccin
get
bodi
mucou
membran
nose
explor
certain
type
vaccin
addit
two
method
vaccin
immun
system
complex
fantast
bodi
system
protect
peopl
bacteria
virus
toxin
danger
pathogen
germ
howev
peopl
often
take
immun
system
grant
someth
goe
wrong
past
medic
scienc
primarili
work
way
cure
alreadyexist
ill
diseas
today
grow
emphasi
prevent
ill
boost
immun
system
strength
boost
bodi
immun
system
help
keep
bodi
peak
condit
fight
repel
destroy
infect
virus
bacteria
mani
way
help
keep
immun
system
function
highest
potenti
someon
take
care
immun
system
immun
system
turn
take
care
physic
exercis
keep
bodi
fit
activ
well
help
bodi
circul
lymph
throughout
bodi
simpli
min
moder
exercis
day
help
immun
system
optim
carri
defens
addit
healthi
balanc
diet
suffici
amount
qualiti
sleep
good
hygien
habit
emot
health
healthi
weight
practic
prevent
etc
help
maintain
sound
health
immun
system
natur
immun
system
booster
herbal
antibiot
known
prevent
infect
ill
synthet
chemic
agent
may
advers
effect
bodi
condit
herbal
agent
act
fantabul
herbal
agent
found
zero
side
effect
show
action
herbal
immun
boost
agent
safe
effect
phenomenon
present
sinc
age
eg
concept
chyawanprash
ayurved
tradit
develop
year
ago
chyawanprash
mixtur
larg
number
herb
includ
amla
ingredi
claim
poss
antioxid
immunomodulatori
properti
mani
herbal
immun
booster
avail
natur
natur
remedi
immun
system
booster
natur
herbal
remedi
provid
much
need
assist
strengthen
immun
system
get
bodi
natur
defens
mechan
top
shape
holist
medicin
recogn
ill
caus
primarili
weaken
immun
system
pathogen
import
rememb
microorgan
like
flu
viru
tb
etc
around
peopl
time
mostli
manag
resist
becom
ill
boost
immun
system
natur
allow
human
bodi
fight
infecti
agent
without
drawback
convent
medic
wide
select
medicin
herb
well
known
immun
strengthen
properti
even
safe
children
allow
bodi
resolv
infect
without
antibiot
also
help
strengthen
immun
system
futur
attack
black
elderberri
sambucu
nigra
natur
immun
booster
nativ
europ
long
histori
use
herbal
medicin
echinacea
purpurea
american
herb
becom
famou
antivir
antifung
antibacteri
properti
excel
immun
system
tonic
boost
bodi
immun
stimul
product
immun
cell
astragalu
membranac
use
centuri
tradit
chines
medicin
tone
immun
system
astragalu
ideal
remedi
anyon
prone
recurr
infect
common
cold
abl
increas
bodi
resist
immun
respons
ill
v
album
commonli
known
enhanc
immunestimul
properti
ingredi
encourag
repair
damag
cell
mani
herb
proven
improv
immun
function
natur
ingredi
immun
boost
properti
paniculata
chondru
crispu
irish
moss
crataegu
monogyna
hawthorn
c
oxycanthoid
eleutherococcu
senticosu
siberian
ginseng
ficu
carica
glycyrrhiza
glabra
h
officinali
hypoxi
rooperi
african
star
grasswild
potato
inula
helenium
mentha
piperita
olea
europaea
oliv
panax
ginseng
panax
spp
p
emblica
rosmarinu
officinali
rosemari
schisandra
chinensi
solidago
virgaurea
thymu
vulgari
thyme
verbascum
thapsu
mullein
w
somnifera
etc
act
excel
immun
booster
speci
medicin
mushroom
includ
auricularia
auricula
polytricha
agaricu
bisporu
common
mushroom
blazei
god
mushroom
subrufescen
agrocyb
aegerita
chestnut
mushroom
boletu
eduli
coprinu
comatu
cordycep
sinensi
caterpillar
fungu
flammulina
velutip
enokitak
fome
fomentariu
tinder
conk
mushroom
g
lucidum
reishi
grifola
frondosa
maitak
hericium
erinaceu
lion
mane
mushroom
hypsizygu
tessel
inonotu
obliquu
chaga
mushroom
lentinula
edod
shiitak
phallu
indusiatu
phellinu
linteu
mesima
pleurotu
citrinopileatu
p
djamor
p
ostreatu
oyster
mushroom
p
eryngii
king
oyster
mushroom
piptoporu
betulinu
p
betulinu
birch
bracket
mushroom
schizophyllum
commun
splitgil
sparassi
crispa
cauliflow
mushroom
tinder
polypor
tramet
versicolor
turkey
tail
tricholoma
matsutak
ustilago
maydi
volvariella
volvacea
import
purpos
medicin
mushroom
use
treat
prevent
wide
array
ill
use
immun
stimul
immun
modul
adaptogen
antioxid
natur
medicin
go
long
way
help
strengthen
immun
system
ill
diseas
infect
immun
stimul
natur
product
use
help
treat
cancer
fight
infect
initi
immun
respons
result
higher
level
white
blood
cell
cytokin
antibodi
complement
protein
one
top
immuneenhanc
herb
ginger
z
officinal
benefit
immun
system
antibacteri
antivir
antiparasit
activ
activ
certain
type
cancer
stimul
phagocytosi
activ
tcell
modul
herbal
immun
boost
prepar
home
made
follow
ingredi
like
part
echinacea
root
part
thyme
part
licoric
part
elderberri
cup
hot
tea
prepar
ad
teaspoon
premix
herb
cup
boil
water
let
steep
min
strain
add
honey
raw
best
tast
make
pitcher
tea
store
refriger
use
teaspoon
premix
herb
cup
boil
water
let
cool
strain
discard
use
herb
put
tea
refriger
drink
ice
reheat
biotechnolog
applic
four
major
industri
area
includ
health
care
medic
crop
product
agricultur
nonfood
industri
use
crop
product
eg
biodegrad
plastic
veget
oil
biofuel
environment
use
biotechnolog
healthcar
sector
along
develop
infrastructur
manpow
research
etc
includ
develop
manufactur
biolog
reagent
biodiagnost
biotherapeut
prevent
therapeut
prophylact
vaccin
etc
promot
biomed
innov
product
peptid
hormon
new
interferon
lymphokin
microbi
cell
cultur
new
enzym
inhibitor
microbi
origin
import
health
care
pharmaci
biotechnolog
chang
health
care
deliveri
profound
way
pharmacogenom
new
genom
tool
emerg
biotechnolog
revolution
medicin
transform
understand
health
provis
healthcar
biotechnolog
contribut
discoveri
manufactur
tradit
small
molecul
pharmaceut
drug
well
drug
product
biotechnologybiopharmaceut
exampl
hightech
herbal
medicin
plantbas
vaccin
use
potato
tuber
biofactori
recombin
antibodi
etc
vaccin
help
stimul
antibodi
produc
human
anim
provid
immun
protect
sever
diseas
plantbas
vaccin
product
mainli
involv
integr
transgen
plant
cell
herbal
plantbas
vaccin
technolog
involv
integr
desir
gene
encod
antigen
protein
specif
diseas
genom
plant
tissu
plant
start
produc
exact
protein
use
vaccin
agrobacteriummedi
gene
transfer
transform
via
genet
modifi
plant
viru
common
method
use
produc
effect
vaccin
new
method
biolist
electropor
agroinfiltr
sonic
polyethylen
glycol
treatment
etc
develop
increas
effici
former
method
flexibl
plant
express
vaccin
system
combin
low
cost
abil
massiv
scale
may
provid
vaccin
protect
citizen
develop
well
develop
countri
world
current
afford
vaccin
use
plantexpress
vaccin
includ
success
creation
edibl
banana
protect
norwalk
viru
tabl
show
exampl
plantbas
vaccin
human
anim
diseas
prevent
better
cure
proverb
impli
unwis
becom
diseas
go
treatment
get
rid
curs
impos
diseas
rather
diseas
prevent
attack
alway
safe
prevent
enemi
attack
boost
immun
system
prohibit
entri
microorgan
better
act
upon
later
immunotherapi
medic
term
defin
treatment
diseas
induc
enhanc
suppress
immun
respons
immunotherapi
design
elicit
amplifi
immun
respons
classifi
activ
immunotherapi
immunotherapi
reduc
suppress
classifi
suppress
immunotherapi
cancer
immunotherapi
attempt
stimul
immun
system
reject
destroy
tumor
dr
william
coley
use
coley
toxin
late
crude
immunotherapi
success
immunocel
therapi
cancer
first
introduc
rosenberg
colleagu
nation
institut
health
usa
late
publish
articl
report
low
tumor
regress
rate
patient
metastat
cancer
underw
differ
type
activ
specif
immunotherapi
asi
suggest
immunocel
therapi
along
specif
chemotherapi
futur
cancer
immunotherapi
initi
immunotherapi
treatment
involv
administr
cytokin
interleukin
thereaft
advers
effect
intraven
administ
cytokin
lead
extract
lymphocyt
blood
expand
vitro
tumor
antigen
inject
cell
appropri
stimulatori
cytokin
cell
specif
target
destroy
tumor
express
antigen
rais
concept
treatment
start
us
fulli
fledg
clinic
treatment
routin
basi
practic
japan
sinc
random
control
studi
differ
cancer
result
signific
increas
surviv
diseasefre
period
report
efficaci
enhanc
cellbas
immunotherapi
combin
convent
treatment
method
bcg
immunotherapi
earli
stage
noninvas
bladder
cancer
util
instil
attenu
live
bacteria
bladder
effect
prevent
recurr
twothird
case
topic
immunotherapi
util
immun
enhanc
cream
imiquimod
interferon
produc
caus
patient
killer
tcell
destroy
wart
actin
keratos
basal
cell
cancer
vagin
intraepitheli
neoplasia
squamou
cell
cancer
cutan
lymphoma
superfici
malign
melanoma
inject
immunotherapi
use
mump
candida
hpv
vaccin
trichophytinantigen
inject
treat
wart
hpv
induc
tumor
lung
cancer
demonstr
potenti
respond
immunotherapi
dendrit
cell
dc
profession
antigenpres
cell
apc
found
tissu
bodi
particularli
abund
interfac
extern
intern
environ
eg
skin
lung
mucosa
lymphoid
tissu
line
gastrointestin
tract
dc
get
name
surfac
project
resembl
dendrit
neuron
main
function
process
antigen
present
cell
promot
immun
foreign
antigen
toler
selfantigen
also
secret
cytokin
regul
immun
respons
activ
migrat
lymph
node
interact
tcell
bcell
initi
shape
adapt
immun
respons
act
messeng
innat
adapt
immun
system
dendrit
cell
stimul
activ
cytotox
respons
toward
antigen
dendrit
cell
type
antigenpres
cell
harvest
patient
cell
either
puls
antigen
transfect
viral
vector
upon
transfus
back
patient
activ
cell
present
tumor
antigen
effector
lymphocyt
cell
cell
b
cell
initi
cytotox
respons
occur
cell
express
tumor
antigen
adapt
respons
prime
cancer
vaccin
sipuleucelt
one
exampl
approach
dcbase
vaccin
repres
promis
approach
immunotherapi
cancer
infecti
diseas
dc
play
essenti
role
initi
cellular
immun
respons
adopt
cell
transfer
use
tcellbas
cytotox
respons
attack
cancer
cell
tcell
natur
genet
engin
reactiv
patient
cancer
gener
vitro
transfer
back
cancer
patient
one
studi
use
autolog
tumorinfiltr
lymphocyt
effect
treatment
patient
metastat
melanoma
achiev
take
tcell
found
tumor
patient
train
attack
cancer
cell
tcell
refer
tumorinfiltr
lymphocyt
til
encourag
multipli
vitro
use
high
concentr
alloreact
feeder
cell
tcell
transfer
back
patient
along
exogen
administr
boost
anticanc
activ
thu
far
object
respons
rate
observ
patient
tumor
shrank
undetect
size
initi
studi
adopt
cell
transfer
use
til
howev
reveal
persist
transfer
cell
vivo
short
reinfus
lymphodeplet
recipi
requir
elimin
regulatori
tcell
well
normal
endogen
lymphocyt
compet
transfer
cell
homeostat
cytokin
lymphodeplet
made
total
bodi
irradi
prior
transfer
expand
til
trend
increas
surviv
function
increas
lymphodeplet
highli
signific
p
transfer
cell
expand
vivo
persist
peripher
blood
mani
patient
sometim
achiev
level
tcell
month
infus
clinic
trial
base
adopt
cell
transfer
til
patient
metastat
melanoma
current
ongo
nation
cancer
institut
bethesda
md
usa
moffitt
cancer
center
tampa
fl
usa
md
anderson
cancer
center
houston
tx
usa
sheba
medic
center
tel
hashom
israel
herlev
univers
hospit
herlev
denmark
nki
antoni
van
leeuwenhoek
amsterdam
netherland
autolog
immun
enhanc
therapi
aiet
autolog
immun
cellbas
therapi
wherein
patient
peripher
bloodderiv
nk
cell
cytotox
tlymphocyt
relev
immun
cell
expand
vitro
reinfus
tackl
cancer
also
studi
prove
efficaci
hepat
c
viral
infect
chronic
fatigu
syndrom
infect
contain
copi
cell
receptor
tcr
gene
special
recogn
tumor
antigen
viru
abl
reproduc
within
cell
howev
integr
human
genom
benefici
new
tcr
gene
remain
stabl
tcell
patient
tcell
expos
virus
expand
nonspecif
stimul
use
genet
engin
tcr
cell
transfer
back
patient
readi
immun
respons
tumor
morgan
et
al
demonstr
adopt
cell
transfer
lymphocyt
transduc
retroviru
encod
tcr
recogn
cancer
antigen
abl
mediat
antitumor
respons
patient
metastat
melanoma
therapi
demonstr
result
object
clinic
respons
patient
refractori
stage
iv
cancer
surgeri
branch
nation
cancer
institut
bethesda
maryland
activ
investig
form
cancer
treatment
patient
suffer
aggress
melanoma
use
adopt
cell
transfer
genet
engin
tcell
promis
new
approach
treatment
varieti
cancer
one
case
studi
unit
state
doctor
clinic
research
divis
led
dr
cassian
yee
fred
hutchinson
cancer
research
center
seattl
success
treat
patient
advanc
skin
cancer
inject
patient
immun
cell
clone
immun
system
patient
free
tumour
within
week
treatment
dr
cassian
yee
describ
research
find
cancer
research
institut
intern
symposia
seri
respons
howev
seen
patient
clinic
trial
larger
trial
way
potenti
use
immunotherapi
known
restor
immun
system
patient
immun
defici
result
infect
chemotherapi
exampl
cytokin
test
clinic
trial
clinic
trial
hiv
cancer
patient
addit
also
test
hiv
patient
antimicrobi
immunotherapi
includ
vaccin
involv
activ
immun
system
respond
infecti
agent
immun
suppress
dampen
abnorm
immun
respons
autoimmun
diseas
reduc
normal
immun
respons
prevent
reject
transplant
organ
cell
immunosuppress
drug
import
tool
manag
organ
transplant
autoimmun
diseas
immun
respons
depend
lymphocyt
prolifer
cytostat
drug
immunosuppress
glucocorticoid
somewhat
specif
inhibitor
lymphocyt
activ
wherea
inhibitor
immunophilin
specif
target
lymphocyt
activ
immunosuppress
antibodi
target
increasingli
broad
array
step
immun
respons
still
drug
modul
immun
respons
immun
toler
process
bodi
natur
launch
immun
system
attack
tissu
immun
toler
therapi
seek
reset
immun
system
bodi
stop
mistakenli
attack
organ
cell
autoimmun
diseas
accept
foreign
tissu
organ
transplant
brief
treatment
reduc
elimin
need
lifelong
immunosuppress
chanc
attend
side
effect
case
transplant
preserv
bodi
function
least
part
case
type
diabet
autoimmun
disord
immunotherapi
also
use
treat
allergi
allergi
treatment
antihistamin
corticosteroid
treat
symptom
allerg
diseas
immunotherapi
avail
treatment
modifi
natur
cours
allerg
diseas
reduc
sensit
allergen
individu
tailor
regimen
inject
may
result
longterm
benefit
recent
research
suggest
patient
complet
immunotherapi
may
continu
see
benefit
year
come
immunotherapi
work
everyon
partli
effect
peopl
offer
allergi
suffer
chanc
eventu
reduc
stop
symptomaticrescu
medic
therapi
indic
peopl
extrem
allerg
avoid
specif
allergen
exampl
may
abl
live
normal
life
complet
avoid
pollen
dust
mite
mold
spore
pet
dander
insect
venom
certain
common
trigger
allerg
reaction
immunotherapi
gener
indic
food
medicin
allergi
immunotherapi
typic
individu
tailor
administ
allergist
allergologist
special
physician
offic
inject
schedul
avail
healthcar
system
prescrib
famili
physician
therapi
particularli
use
peopl
allerg
rhiniti
asthma
therapi
particularli
like
success
begin
earli
life
soon
allergi
develop
first
time
past
call
serum
incorrect
name
allergist
call
mixtur
allergi
extract
first
shot
contain
tini
amount
allergen
antigen
one
allerg
progress
increas
dosag
time
one
bodi
adjust
allergen
becom
less
sensit
process
known
desensit
recent
approv
sublingu
tablet
grazax
contain
grass
pollen
extract
similarli
effect
side
effect
selfadminist
home
includ
patient
also
suffer
allerg
asthma
condit
preclud
use
injectionbas
desensit
read
topic
see
allergi
hyposensit
recent
research
clinic
effect
whipworm
ova
trichuri
sui
hookworm
necat
americanu
treatment
certain
immunolog
diseas
allergi
mean
organ
must
classifi
immunotherapeut
agent
helminth
therapi
investig
potenti
highli
effect
treatment
symptom
diseas
process
disord
relapsingremit
multipl
sclerosi
crohn
allergi
asthma
precis
mechan
helminth
modul
immun
respons
ensur
surviv
host
incident
effect
modul
autoimmun
diseas
process
current
unknown
howev
sever
broad
mechan
postul
repolar
respons
modul
dendrit
cell
function
helminth
downregul
proinflammatori
cytokin
interferon
gamma
ifnc
tumour
necrosi
factoralpha
promot
product
regulatori
cytokin
helminth
modul
host
immun
respons
proven
core
assert
hygien
hypothesi
appear
recent
public
studi
demonstr
coevolut
helminth
shape
least
gene
associ
interleukin
express
immunolog
disord
like
crohn
ulcer
coliti
celiac
diseas
much
research
publish
indic
key
role
tradit
regard
diseasecaus
organ
relationship
human
host
classifi
parasit
rather
mutualist
symbiont
develop
biotechnolog
origin
potenti
applic
health
care
human
anim
sector
contribut
biotechnolog
frequent
notabl
reward
financi
psycholog
difficult
summar
whole
gamut
contribut
text
limit
space
could
group
follow
broad
head
diseas
prevent
ii
diseas
detect
iii
therapeut
agent
iv
correct
genet
diseas
v
fertil
control
vi
forens
medicin
aim
highlight
major
develop
categori
cite
appropri
exampl
prevent
diseas
desir
conveni
highli
effect
approach
health
achiev
vaccin
immun
use
biolog
prepar
call
vaccin
vaccin
repres
invalu
contribut
biotechnolog
provid
protect
even
diseas
effect
cure
yet
avail
effect
vaccin
may
appreci
fact
smallpox
dread
diseas
world
complet
erad
world
last
case
smallpox
report
variou
vaccin
group
follow
type
convent
vaccin
live
vaccin
inactiv
pathogen
ii
purifi
antigen
vaccin
iii
recombin
vaccin
recombin
proteinspolypeptid
dna
vaccin
fig
convent
vaccin
consist
whole
pathogen
organ
may
either
kill
bacteri
vaccin
viral
vaccin
live
vaccin
virul
pathogen
greatli
reduc
attenu
viral
vaccin
convent
vaccin
although
highli
effect
rel
easi
produc
low
cost
suffer
follow
limit
mani
case
live
vaccin
use
sinc
kill
pathogen
vaccin
ineffect
ii
live
vaccin
gener
base
cultur
anim
cell
henc
expens
tissu
cultur
setup
essenti
iii
live
vaccin
heatlabil
due
pathogen
inactiv
heat
iv
convent
vaccin
carri
variabl
risk
diseas
develop
due
occasion
presenc
activ
viru
particl
case
inactiv
vaccin
eg
outbreak
footandmouth
diseas
europ
revers
virul
replic
vaccin
individu
case
attenu
live
vaccin
case
case
live
polio
vaccin
v
mani
case
difficult
produc
eg
hepat
b
viru
doc
grow
high
titer
cultur
cell
limit
prompt
success
develop
vaccin
base
purifi
antigen
recombin
vaccin
rather
costli
least
present
vaccin
base
purifi
antigen
isol
concern
pathogen
ie
nonrecombin
sinc
contain
organ
risk
pathogen
avoid
howev
cost
higher
due
step
involv
purif
vaccin
prepar
mani
isol
antigen
poorli
immunogen
success
exampl
vaccin
mostli
bacteria
eg
vaccin
base
polysaccharid
antigen
bacteri
cell
wall
capsul
neisseria
mening
caus
mening
streptococcu
pneumonia
caus
pneumonia
mani
bacteria
produc
exotoxin
highli
immunogen
toxin
produc
toxic
effect
intens
decreas
storag
declin
acceler
heat
formaldehyd
chemic
fortun
mani
exotoxin
lost
toxic
retain
immunogen
call
toxoid
use
effect
vaccin
eg
toxoid
pathogen
caus
tetanu
diphtheria
gangren
etc
precipit
toxoid
alum
enhanc
immunogen
toxoid
vaccin
quit
effect
cheap
toxoid
good
adjuv
ie
increas
immunogen
antigen
eg
diphtheria
toxoid
exampl
b
polysaccharid
haemophilu
influenza
poorli
immunogen
b
polysaccharid
combin
diphtheria
toxoid
immunogen
greatli
increas
mani
case
adjuv
activ
use
great
advantag
sinc
isol
antigen
pathogen
poorli
immunogen
recombin
vaccin
contain
either
protein
gene
encod
protein
pathogen
origin
immunogen
critic
pathogen
function
vaccin
produc
use
recombin
dna
technolog
vaccin
base
recombin
protein
protein
produc
recombin
dna
technolog
also
call
subunit
vaccin
logic
vaccin
simpl
term
follow
protein
gener
immunogen
mani
critic
pathogen
organ
gene
encod
protein
identifi
isol
pathogen
express
e
coli
suitabl
host
mass
product
protein
concern
protein
purifi
mix
suitabl
stabil
adjuv
requir
use
immun
differ
step
involv
develop
recombin
proteinbas
vaccin
may
simpli
summar
follow
first
step
identifi
protein
immunogen
critic
pathogen
ii
gene
encod
protein
identifi
isol
iii
gene
integr
suitabl
express
vector
introduc
suitabl
host
express
protein
larg
quantiti
iv
protein
isol
purifi
host
cell
v
use
prepar
vaccin
host
organ
use
express
immunogen
protein
use
vaccin
may
one
follow
genet
engin
microorgan
eg
yeast
express
hepat
surfac
antigen
hbsag
use
vaccin
hepat
b
viru
vaccin
approv
market
india
tabl
ii
cultur
anim
cell
eg
hbsag
express
cho
chines
hamster
ovari
chines
hamster
ovari
cell
line
cell
line
vaccin
advanc
stage
develop
iii
transgen
plant
eg
hbsag
human
immunodefici
viru
epitop
rhinoviru
epitop
last
two
use
vaccin
experiment
stage
iv
insect
larva
gene
integr
baculoviru
dna
virus
use
infect
insect
larva
often
high
quantiti
recombin
protein
produc
exampl
total
protein
spodoptera
exigua
larva
infect
recombin
baculoviru
recombin
protein
protein
purifi
use
vaccin
may
use
diagnost
test
without
purif
approach
also
use
produc
monoclon
antibodi
uncommon
antigen
eg
alzheim
protein
far
larg
number
recombin
immunogen
protein
pathogen
produc
evalu
gener
major
protein
ineffect
poorli
effect
immun
case
least
problem
may
due
essenti
requir
immunogen
protein
present
specif
aggreg
form
eg
hbsag
use
effect
immun
form
viruslik
particl
nm
thu
far
hepat
b
vaccin
good
exampl
recombin
protein
vaccin
antimalari
vaccin
base
recombin
circumsporozoit
protein
sporozoit
stage
parasit
plasmodium
falciparum
advanc
stage
develop
gener
whole
protein
molecul
necessari
immunogen
immunogen
properti
usual
confin
small
portion
protein
molecul
exampl
immunogen
footandmouth
diseas
viru
coat
protein
due
amino
acid
also
segment
protein
contain
either
two
amino
acid
sequenc
effect
immun
induc
antibodi
neutral
viru
therebi
provid
protect
footandmouth
diseas
similarli
immunogen
coat
protein
felin
leukemia
viru
flv
due
acid
long
segment
segment
produc
partial
immunogen
respons
guinea
pig
tabl
show
ghosh
product
gener
genet
engin
microb
gem
product
either
current
therapeut
use
advanc
stage
develop
case
immunogen
protein
may
compos
two
distinct
polypeptid
case
may
desir
use
one
polypeptid
vaccin
variou
reason
exampl
cholera
enterotoxin
produc
vibrio
cholera
consist
polypeptid
viz
b
polypeptid
polypeptid
toxic
b
polypeptid
nontox
immunogen
gene
encod
b
polypeptid
clone
recombin
b
polypeptid
thu
produc
use
vaccin
cholera
recombin
b
polypeptid
use
combin
inactiv
cholera
cell
oral
vaccin
place
convent
inject
vaccin
recombin
protein
polypeptid
vaccin
safe
sinc
whole
organ
involv
also
high
efficaci
cost
high
often
prohibit
sinc
produc
either
bacteri
ferment
anim
cell
cultur
ii
store
low
temperatur
sinc
heat
destabil
protein
iii
make
storag
transport
especi
develop
countri
problemat
often
limit
recent
vaccin
base
dna
develop
result
obtain
influenza
viru
advanc
stage
test
quit
excit
regard
third
revolut
vaccin
strategi
dna
vaccin
follow
gene
encod
relev
immunogen
protein
isol
clone
integr
suitabl
express
vector
prepar
introduc
individu
immun
gene
ultim
express
vaccin
individu
immunogen
protein
express
suffici
quantiti
invok
humor
cellmedi
immun
may
point
cellmedi
immun
respons
essenti
recoveri
infecti
diseas
variou
approach
dna
vaccin
follow
inject
pure
dna
rna
prepar
muscl
ii
use
vector
eg
vaccinia
virus
adenovirus
retrovirus
e
coli
salmonella
typhimurium
herp
virus
etc
deliveri
gene
iii
reimplant
autolog
cell
cell
individu
vaccin
gene
transfer
iv
particl
gun
deliveri
plasmid
dna
contain
gene
express
cassett
inject
pure
dna
rna
skelet
muscl
lead
uptak
express
dna
muscl
cell
gene
encod
immunogen
protein
introduc
express
also
result
immun
individu
approach
potenti
deliveri
dna
vaccin
dna
like
enter
skelet
muscl
cell
transient
discontinu
plasma
lemma
produc
stretch
muscl
cell
exercis
anoth
approach
remov
cell
bodi
individu
concern
immunogen
encod
gene
introduc
express
cell
reintroduc
bodi
individu
varieti
way
eg
simpl
infus
implant
encapsul
etc
approach
although
cumbersom
advantag
enabl
control
modifi
cell
within
contain
immunogen
encod
gene
may
integr
express
plasmid
purifi
coat
gold
tungsten
particl
introduc
skin
cell
particl
gun
antigenencod
gene
introduc
skin
mice
guinea
pig
elicit
humor
immun
respons
known
cellular
immun
also
induc
plasmid
dna
noninfecti
heat
stabl
offer
advantag
viralbacteri
vector
skin
cell
usual
shed
day
inocul
longterm
persist
modifi
cell
approach
hold
consider
promis
employ
live
vector
deliveri
immunogenencod
gene
vaccin
individu
advanc
promis
vector
vaccinia
virus
adenovirus
e
coli
typhimurium
poxvirus
herpesvirus
etc
concern
gene
introduc
genom
select
viralbacteri
vector
suitabl
attenu
live
microorgan
use
vaccin
variou
vector
studi
vaccinia
viru
appear
promis
vaccinia
viru
w
close
rel
variola
viru
caus
smallpox
use
vaccin
gener
protect
smallpox
viru
mani
use
featur
includ
stabil
freezedri
prepar
low
product
cost
simpl
administr
raptur
skin
cell
vv
offer
possibl
site
integr
express
foreign
gene
gener
antigen
encod
gene
insert
within
thymidin
kinas
tkj
locu
make
viru
tk
attenu
pathogen
attenu
vv
achiev
integr
genom
lymphokin
gene
like
interferon
gamma
ifnc
ifnc
addit
adjuv
activ
promot
immunogen
introduc
antigen
level
compar
complet
freund
adjuv
larg
number
gene
encod
antigen
protein
integr
w
genom
use
vaccin
antigen
includ
viral
protein
like
rabi
viru
glycoprotein
herp
simplex
viru
glycoprotein
hepat
b
surfac
antigen
vesicular
stomat
glycoprotein
etc
recombin
vaccinia
virus
induc
humor
cellular
immun
protect
immun
anim
concern
virus
recent
highli
effect
vaccin
rinderpest
viru
develop
insert
viral
gene
h
f
vv
gene
tk
ha
cattl
immun
recombin
vv
vaccin
complet
protect
even
challeng
time
normal
lethal
inoculum
recombin
vv
vaccin
rabi
also
highli
effect
antigen
hiv
produc
recombin
vv
experiment
anim
human
volunt
antigen
induc
delect
cellular
immun
express
hiv
protein
recombin
vv
contain
chimer
gene
ifng
structur
protein
quit
promis
candid
sale
vaccin
sever
antigen
encod
gene
differ
pathogen
may
incorpor
singl
vv
genom
recombin
vv
vaccin
produc
immun
sever
diseas
singl
inocul
vaccin
call
polyval
vaccin
littl
data
effici
vaccin
use
dna
immun
often
call
genet
immun
recombin
vv
transmit
vaccin
contact
anim
ii
induc
humor
cellular
immun
respons
individu
previous
immun
expos
infect
vv
may
respond
poorli
recombin
vv
vaccin
addit
ii
children
adult
congenit
acquir
immunodefici
may
run
risk
sever
infect
could
resolv
incorpor
vv
genom
gene
ifnc
dna
vaccin
offer
follow
advantag
purif
prepar
dna
vaccin
easier
cheaper
rapid
ii
safer
specif
high
puriti
iii
elicit
potent
immun
respons
purifi
protein
vaccin
accur
diagnosi
diseas
causal
organ
critic
effect
manag
cure
convent
diseas
diagnosi
base
follow
microscopi
specimen
tissu
bodi
fluid
excreta
pu
exud
etc
subject
microscop
examin
detect
causal
organ
eg
stool
examin
ova
cyst
ii
cultur
specimen
specif
select
media
allow
specif
pathogen
grow
test
suscept
variou
therapeut
agent
eg
antibiot
iii
detect
measur
pathogenspecif
antibodi
produc
patient
respons
invas
pathogen
eg
case
viral
infect
test
often
tediou
take
long
time
eg
cultur
method
may
yield
ambigu
result
eg
immunolog
assay
sinc
base
polyclon
antibodi
appli
certain
case
eg
antibodi
liter
estim
case
latent
viral
infect
novel
diagnost
approach
develop
biotechnolog
precis
rapid
viz
probe
ii
monoclon
antibodi
probe
small
base
long
nucleotid
dnarna
sequenc
use
detect
presenc
complementari
sequenc
nucleic
acid
sampl
dna
rna
use
probe
probe
prepar
mani
way
either
radioact
nonradioact
label
probe
use
clinic
diagnosi
detect
microorgan
variou
sampl
eg
tissu
excreta
bodi
fluid
etc
use
probe
diseas
diagnosi
offer
sever
advantag
convent
diagnost
tool
briefli
list
highli
specif
rel
rapid
much
simpler
ii
extrem
power
especi
combin
pcr
even
singl
molecul
test
sampl
detect
iii
sinc
cultur
microb
requir
risk
accident
infect
laboratori
personnel
elimin
consider
time
save
iv
applic
even
organ
cultur
v
probe
detect
even
latent
viral
infect
lead
increas
antibodi
titer
blood
vi
singl
speciesspecif
probe
identifi
serotyp
pathogen
may
requir
separ
antibodi
vii
pure
probe
prepar
rel
easili
obtain
howev
sinc
probe
usual
radioact
label
present
health
hazard
handl
dispos
therefor
emphasi
shift
nonradioact
label
probe
probe
avail
detect
varieti
pathogen
microorgan
tabl
probe
use
follow
hybrid
dot
blot
southern
situ
ii
ligas
chain
reaction
lcr
hybridizationdna
may
isol
test
sampl
subject
southern
blot
dot
blot
hybrid
probe
dot
blot
analys
test
sampl
like
blood
gener
lyse
directli
nitrocellulos
filter
probe
hybrid
test
dna
sampl
latter
contain
complementari
sequenc
probe
use
diagnost
assay
highli
specif
concern
pathogen
microorgan
therefor
posit
hybrid
signal
test
dna
sampl
given
probe
reveal
presenc
concern
microorgan
probe
use
hybrid
assay
use
microscop
prepar
tissu
gener
tissu
fix
formalin
embed
paraffin
section
stain
convent
stain
like
eosin
hematoxylin
routin
examin
subsequ
probe
use
situ
hybrid
detect
presenc
concern
pathogen
approach
prove
quit
use
detect
viral
pathogen
cytopatholog
data
obtain
routin
microscop
observ
correl
presenc
specif
pathogen
obtain
greater
insight
ligas
chain
reaction
clinic
sampl
prepar
accord
protocol
liber
dna
present
sampl
ii
prepar
clinic
sampl
ad
reaction
mixtur
contain
thermost
dna
ligas
vast
excess
two
doublestrand
oligonucleotid
probe
specif
pathogen
detect
nad
nicotinamid
adenin
dinucleotid
two
probe
bluntend
repres
contigu
segment
pathogen
genom
base
long
therefor
target
sequenc
base
long
target
sequenc
must
specif
pathogen
detect
iii
reaction
mixtur
heat
thermocycl
also
use
pcr
ensur
strand
separ
target
dna
probe
iv
temperatur
lower
allow
probe
pair
target
dna
ligas
join
adjac
one
strand
probe
phosphat
probe
strand
complementari
strand
two
probe
also
similarli
join
product
ligat
two
probe
call
amplicon
second
cycl
ligas
chain
reaction
lcr
initi
heat
reaction
mixtur
subsequ
cycl
lcr
target
dna
amplicon
serv
target
probe
result
amplif
lead
exponenti
amplif
amplicon
amplicon
detect
gel
electrophoresi
reaction
mixtur
ethidium
bromid
stain
view
uv
light
alway
one
band
correspond
probe
use
amplif
second
band
equal
size
sum
size
two
probe
appear
target
sequenc
ie
concern
pathogen
present
test
sampl
lcr
highli
effici
detect
target
molecul
sampl
ii
highli
specif
rare
produc
fals
posit
signal
contrast
pcr
iii
lcr
procedur
allow
autom
detect
employ
fluoresc
hapten
label
probe
lcr
use
detect
wide
varieti
infecti
agent
eg
chlamydia
trachomati
mycobacterium
tuberculosi
neisseria
gonorrhoea
herp
simplex
viru
hsv
hiv
hepat
b
viru
hepat
c
viru
etc
lcr
bluntend
probe
duplex
pair
target
sequenc
also
becom
ligat
low
frequenc
call
targetindepend
ligat
limit
sensit
lcr
target
molecul
per
sampl
problem
overcom
use
probe
molecul
stagger
end
call
gap
ligas
chain
reaction
glcr
glcr
abl
detect
target
moleculessampl
glcr
also
use
thermost
dna
polymeras
anoth
modif
lcr
call
asymmetr
gap
lcr
aglcr
also
util
revers
transcriptas
specif
rna
detect
monoclon
antibodi
mab
prepar
specif
singl
antigen
determin
epitop
singl
antigen
mab
usual
produc
hybridoma
clone
clone
deriv
fusion
singl
myeloma
cell
singl
antibodi
produc
lymphocyt
mab
produc
varieti
antigen
employ
mani
purpos
includ
diseas
diagnosi
mab
employ
classif
blood
group
abo
rh
etc
ii
clear
specif
detect
pathogen
iii
earli
accur
detect
cancer
immunolog
assay
gener
employ
diagnost
purpos
vari
elisa
rapid
conveni
highli
effici
recent
techniqu
call
immunopcr
develop
use
detect
rare
antigen
singl
cell
level
even
singl
antigen
molecul
sampl
detect
immunopcr
techniqu
use
pcr
amplif
marker
dna
segment
attach
antibodi
detect
antigen
antibodi
specif
protocol
immunopcr
may
state
simpl
term
follow
test
sampl
suspect
contain
antigen
ad
microtit
plate
well
antigen
immobil
surfac
well
ii
free
bind
site
microtitr
well
surfac
suitabl
block
iii
antibodi
specif
antigen
detect
ad
well
form
antigenantibodi
complex
occur
well
antigen
present
free
antibodi
remov
wash
iv
molecular
linker
ad
bind
fragment
crystalliz
region
fc
region
antibodi
streptavidinprotein
chimera
versatil
molecular
linker
chimer
linker
bind
fc
domain
antibodi
due
protein
sequenc
also
bind
biotinyl
dna
molecul
due
streptavidin
moieti
linker
molecul
alreadi
complex
marker
dna
molecul
ad
microtitr
well
v
segment
marker
dna
amplifi
pcr
vi
pcr
product
analyz
gel
electrophoresi
largescal
applic
pcr
product
label
use
fluorochrom
hapten
permit
rapid
even
autom
detect
case
lcr
antigenantibodi
complex
form
microtitr
well
contain
target
antigen
antigen
antibodi
employ
test
specif
therefor
pcr
amplif
occur
well
well
pcr
product
therefor
test
sampl
yield
pcr
product
contain
target
antigen
critic
step
step
iv
thorough
wash
done
remov
unbound
nonspecif
hound
antibodi
marker
dna
molecul
increas
precis
assay
immunopcr
highli
precis
extrem
sensit
sever
order
magnitud
sensit
elisa
therefor
ii
detect
rare
antigen
iii
diagnos
patholog
condit
much
earlier
iv
extrem
versatil
appli
even
singl
cell
yield
quantit
estim
antigen
amen
autom
addit
v
rel
simpl
autoantibodi
antibodi
specif
antigen
normal
toler
immun
system
typic
constitu
cell
tissu
anim
question
antigen
call
autoantigen
autoantibodi
produc
condit
autoimmun
may
simpli
describ
attack
immun
system
host
antibodi
either
cellspecif
nonorgan
specif
recogn
varieti
cellular
subcellular
compon
includ
compon
replic
transcript
rna
process
rna
translat
protein
process
antigen
specifi
autoantibodi
use
clinic
diagnosi
associ
autoimmun
diseas
tabl
human
be
suffer
sever
hundr
genet
diseas
almost
produc
singl
recess
mutat
mani
ailment
manag
therei
cure
except
fast
emerg
option
gene
therapi
sect
incid
minim
earli
detect
afflict
fetus
abort
therefor
woman
get
pregnant
probabl
child
suffer
genet
disord
estim
base
histori
husband
famili
knowledg
previou
birth
case
risk
investig
carri
clearcut
specif
diagnosi
obtain
fetal
cell
earlier
fetal
cell
obtain
amniocentesi
ie
withdraw
amniot
fluid
free
cell
fetal
develop
human
embryo
origin
help
hypoderm
syring
amniocentesi
applic
week
later
pregnanc
rather
late
abort
therefor
fetal
cell
obtain
biopsi
trophoblast
villi
extern
part
human
embryo
later
form
part
placenta
biopsi
perform
week
pregnanc
use
endoscop
pass
cervix
uteru
usual
provid
lg
pure
fetal
dna
fetal
cell
present
amniot
fluid
obtain
amniocentesi
recov
centrifug
cultur
obtain
suffici
cell
variou
analys
tissu
obtain
biopsi
trophoblast
villi
usual
enough
assay
rico
cultur
may
necessari
diseas
detect
fetal
cell
use
detect
genet
disord
one
follow
way
determin
karyo
type
cell
provid
inform
variou
syndrom
produc
gross
chromosom
aberr
ii
genet
diseas
produc
defect
proteinsenzym
enzym
mani
protein
identifi
assay
fetal
cell
use
assay
concern
enzym
activ
detect
genet
diseas
least
genet
diseas
detect
assay
activ
specif
enzym
iii
case
genet
diseas
concern
gene
mutat
may
alter
either
abolish
produc
recognit
site
restrict
enzym
rflp
produc
detect
southern
hybrid
sequenc
concern
gene
use
probe
exampl
case
sickl
cell
anemia
mutat
gag
gtg
elimin
recognit
site
restrict
enzym
mst
ii
cctnagg
b
globin
gene
b
gene
hemoglobin
dna
normal
b
test
individu
includ
fetal
sampl
digest
mst
ii
subject
gel
electrophoresi
probe
sequenc
b
globin
gene
test
individu
normal
b
globin
b
gene
band
detect
southern
blot
compar
normal
dna
sickl
cell
mutant
b
globin
b
gene
chang
pattern
detect
manner
fig
heterozygot
show
band
present
normal
sickl
cell
dna
approach
applic
disord
gene
mutat
chang
restrict
pattern
result
approach
gener
applic
iv
gener
approach
util
oligonucleotid
probe
repres
sequenc
alter
gene
mutat
caus
genet
diseas
typic
set
two
separ
probe
use
diseas
one
probe
complementari
normal
sequenc
complementari
mutant
sequenc
probe
radiolabel
use
probe
southern
blot
appropri
condit
probe
distinguish
normal
mutant
dna
sampl
set
two
base
long
oligonucleotid
probe
success
use
detect
sickl
cell
anemia
one
two
probe
b
probe
contain
sequenc
complementari
chang
sickl
cell
mutat
b
probe
complementari
segment
normal
allel
southern
blot
normal
individu
b
b
hybrid
b
probe
sickl
cell
homozygot
b
b
b
probe
heterozygot
hybrid
b
b
probe
similarli
mutant
gene
eg
aantitrypsin
gene
implic
pulmonari
emphysema
differ
normal
allel
singl
base
could
detect
use
approach
approach
gener
applic
detect
rflp
assay
use
case
base
sequenc
gene
segment
contain
mutat
normal
mutant
allel
known
allow
synthesi
two
oligonucleotid
probe
probe
prepar
mutat
due
base
substitut
insert
delet
concern
gene
treatment
diseas
util
wide
varieti
prepar
biolog
abiolog
origin
prepar
biolog
origin
may
either
crude
eg
ayurved
medicin
allopath
drug
etc
purifi
variou
degre
mani
compound
obtain
plant
larg
number
origin
microorgan
cultur
cell
recombin
organ
product
nonrecombin
organ
therapeut
agent
nonrecombin
organ
may
origin
follow
system
larg
number
pharmaceut
origin
microorgan
rang
whole
microorgan
eg
spore
lactobacillu
sporogen
biomass
use
foodfe
supplement
eg
singl
cell
protein
varieti
highli
valuabl
compound
like
antibiot
vitamin
enzym
organ
acid
etc
plant
cell
cultur
biochem
pharmaceut
valu
produc
cultur
plant
cell
eg
shikonin
berberin
ginseng
biomass
taxol
taxol
produc
cell
cultur
taxu
spp
grown
bioreactor
use
treatment
breast
ovarian
cancer
anim
cell
cultur
cultur
anim
cell
sourc
sever
compound
use
treatment
diseas
eg
angiogen
factor
binterferon
etc
product
obtain
nonrecombin
organ
limit
natur
capabl
genet
engin
howev
remov
limit
gene
organ
transfer
express
organ
enabl
product
larg
number
recombin
protein
ie
protein
produc
genet
engin
recombin
dna
technolog
microorgan
cultur
anim
cell
recent
plant
grown
field
product
cost
reduc
case
drastic
exampl
case
interferon
cost
reduc
time
cost
convent
product
deriv
human
blood
ii
risk
contamin
aid
viru
case
convent
produc
protein
usual
human
sourc
iii
produc
far
greater
quantiti
possibl
convent
product
iv
case
protein
human
origin
becom
avail
eg
insulin
convent
anim
origin
could
obtain
interferon
ifn
member
larg
group
protein
call
cytokin
affect
wide
rang
target
cell
tissu
bind
specif
receptor
present
surfac
target
cell
follow
respect
cytokin
resembl
hormon
releas
bloodstream
bodi
fluid
differ
hormon
follow
featur
produc
varieti
cell
type
specif
endocrin
organ
interferon
origin
identifi
due
antivir
activ
protect
viral
infect
interferon
independ
immun
system
interferon
three
major
type
ifna
ifnb
ifnc
ifxa
group
consist
famili
close
relat
protein
usual
divid
two
subfamili
ifnai
ifnaii
mainli
produc
leucocyt
ifnb
singl
protein
speci
produc
leucocyt
fibroblast
ifna
ifnb
share
common
receptor
surfac
target
cell
tabl
mainli
induc
viral
infect
contrast
ifnc
produc
tlymphocyt
respons
antigenactiv
distinct
receptor
ifna
ifnb
mode
ifn
action
clearli
understood
one
pathway
may
involv
ifna
ifnc
bind
receptor
one
tyrosin
kinas
becom
activ
lead
phosphoryl
consequ
activ
transcript
factor
like
interferonstimul
gene
factor
transloc
cytoplasm
nucleu
factor
stimul
transcript
number
gene
includ
encod
synthetas
doublestrand
rna
activ
protein
kinas
pkr
mx
protein
gene
product
protect
cell
rang
virus
addit
ifn
induc
follow
effect
basi
well
understood
ifna
use
signific
scale
treatment
hepat
b
addit
interferon
approv
use
treatment
cancer
viral
diseas
includ
aid
growth
factor
belong
group
protein
call
cytokinesthey
alter
cell
product
organogenesi
diseas
suscept
anim
effect
produc
growth
factor
mainli
depend
presenc
growth
factor
target
cell
receptor
target
cell
nomenclatur
cytokin
confus
term
like
interleukin
growth
factor
colonystimul
factor
etc
use
often
singl
protein
term
interleukin
prefer
one
new
leucocyt
product
design
name
follow
number
eg
variou
growth
factor
group
follow
famili
insulin
like
growth
factor
igf
eg
igfi
igfii
ii
nerv
growth
factor
ngf
iii
epiderm
growth
factor
egf
iv
transform
growth
factor
b
tgfb
v
plateletderiv
growth
factor
pdgf
vi
fibroblast
growth
factor
fgf
vii
hcpatocyt
growth
factor
hgf
viii
hemopoiet
growth
factor
least
cytokin
affect
product
function
blood
cell
mani
growth
factor
approv
treatment
human
diseas
erythropoietin
epo
use
consider
scale
treatment
anemia
conjunct
lak
cell
use
cancer
therapi
similarli
granulocyt
macrophag
colonystimul
factor
granulocyt
colonystimul
factor
use
acceler
neutrophil
recoveri
chemotherapi
bone
marrow
transplant
also
use
stimul
red
blood
cell
product
kidney
dialysi
cancer
patient
sever
growth
factor
beenar
like
approv
similar
applic
antisens
nucleotid
therapeut
agent
effect
specif
approach
treatment
varieti
diseas
design
use
oligonucleotid
say
base
long
complementari
end
parasit
mrna
oligonucleotid
call
antisens
oligonucleotid
antisens
oligonucleotid
may
link
acridin
increas
effect
oligonucleotid
use
cultur
blood
parasit
trypanosoma
brucei
parasit
kill
approach
quit
success
treatment
cancer
antisens
oligonucleotid
variou
stage
evalu
monoclon
antibodi
mab
sever
therapeut
applic
eg
provid
passiv
immun
diseas
ii
treatment
diseas
like
leprosi
mab
prepar
specif
pathogen
administ
regular
interv
iii
deliv
toxin
molecul
immunotoxin
specif
cancer
cell
iv
deliv
radioact
cancer
cell
approach
aim
design
drug
specif
select
fit
critic
site
target
molecul
therebi
inactiv
latter
target
molecul
may
enzym
concern
either
metabol
dna
replic
hormon
receptor
import
molecul
involv
diseas
aim
drug
design
develop
highli
effici
drug
littl
side
effect
drug
normal
deliv
either
oral
parenter
inject
becom
distribut
whole
bodi
tissu
fluid
small
portion
reach
diseas
tissueorgan
necessit
much
larger
dose
expens
drug
may
often
produc
sever
undesir
effect
organstissu
oral
rout
drug
administr
much
desir
inject
obviou
reason
rout
unsuit
new
class
proteinpeptid
drug
due
poor
uptak
proteolyt
degrad
gastrointestin
tract
poor
permeabl
intestin
mucosa
high
molecular
weight
therapeut
agent
follow
approach
develop
effici
andor
target
deliveri
drug
peptideprotein
drug
may
deliv
oilier
rout
eg
nasal
buccal
rectal
ocular
pulmonari
vagin
rout
nasal
rout
appear
promis
epitheli
membran
present
barrier
drug
uptak
overcom
use
compound
enhanc
permeabl
membran
commonli
use
permeabl
enhanc
sodium
glycochol
sodium
deoxychol
dimethylb
cyclodextrin
etc
prolong
use
enhanc
caus
chang
mucos
surfac
therefor
new
better
enhanc
develop
ii
varieti
drug
encapsul
liposom
small
lipid
vesicl
produc
artifici
liposom
disadvantag
larger
size
poor
tissu
cell
type
select
liposom
becom
concentr
liver
spleen
tissu
select
liposom
greyli
increas
attach
surfac
specif
ligand
eg
monoclon
antibodi
mab
polyethylen
glycoli
also
attach
surfac
liposom
mab
surfac
circul
time
well
sitespecif
deliveri
liposom
greatli
increas
liposom
call
stealth
liposom
liposom
hold
great
promis
dna
deliveri
system
gene
therapi
inject
subject
iii
polym
use
drug
deliveri
system
drug
gener
releas
cleavag
drug
polym
swell
polym
drug
trap
within
polymer
chain
osmot
pressur
gener
pore
simpl
diffus
polyest
wide
studi
biodegrad
product
hydrolysi
yield
nontox
alcohol
organ
acid
polyest
lactic
acid
glycol
acid
wide
use
polyest
slow
releas
drug
larg
molecul
eg
protein
polysaccharid
oligonucleotid
drug
deliv
polym
system
includ
insulin
growth
factor
steroid
anticanc
drug
etc
iv
effect
system
sitedirect
deliveri
drug
moieti
call
drug
target
base
monoclon
antibodi
immunotoxin
serv
good
exampl
approach
applic
technolog
limit
low
avail
mab
specif
given
tumor
cell
type
also
chang
surfac
decor
antigen
display
cell
surfac
tumor
cell
intens
research
effort
direct
import
area
diseas
treatment
mani
import
develop
may
expect
near
futur
two
group
basi
end
result
process
addit
augment
gene
therapi
ii
target
gene
transfer
type
somat
cell
gene
therapi
function
gene
introduc
addit
defect
gene
endogen
die
cell
ie
modifi
cell
contain
defect
endogen
well
normal
introduc
copi
gene
two
gener
approach
augment
therapi
first
approach
use
first
two
patient
gene
therapi
attempt
correct
genet
disord
call
sever
combin
immun
defici
scid
syndrom
produc
adenosin
deaminas
ada
defici
normalida
gene
copi
produc
clone
ii
pack
defect
retroviru
viral
gene
replac
ada
gene
iii
lymphocyt
isol
patient
iv
recombin
retrovirus
use
infect
lymphocyt
final
v
infect
cell
express
gene
inject
back
patient
normal
ada
gene
express
patient
ada
defici
partial
correct
result
improv
patient
immun
system
varieti
viral
vector
use
deliv
gene
targetstem
cell
eg
lymphocyt
bone
marrow
cell
cultur
vitro
stem
cell
obtain
either
concern
patient
desir
match
donor
reserv
safeti
retrovir
vector
sought
solv
develop
suicid
vector
replic
alter
deliveri
gene
main
problem
approach
low
frequenc
transfect
stem
cell
ii
stabil
integr
gene
iii
durat
gene
express
iv
lack
proper
regul
gene
express
etc
recent
interest
focuss
physic
method
gene
deliveri
like
ca
phosphat
coprecipit
particl
gun
electropor
etc
second
approach
direct
inject
dna
tissu
either
protein
complex
order
bring
receptormedi
transfer
dna
specif
tissu
eg
liver
even
nake
dna
muscl
skin
interestingli
cell
take
dna
express
gene
product
excit
result
obtain
experiment
famili
hypercholesterolemia
ldl
receptor
level
augment
inject
gene
sialoglycoprotein
complex
problem
approach
well
relat
frequenc
cell
take
express
gene
particularli
durat
express
gene
deliveri
method
use
gene
therapi
also
use
treatment
cancer
aid
case
cancer
toxin
encod
gene
deliv
cancer
cell
similarli
appropri
interleukin
gene
deliv
boost
bodi
defens
mechan
case
aid
target
gene
transfer
gene
target
use
homolog
recombin
replac
endogen
gene
function
introduc
gene
first
case
gene
transfer
use
disrupt
human
gene
cultur
cell
subsequ
mammalian
gene
modifi
approach
gene
target
use
either
inactiv
disrupt
function
endogen
gene
correct
defect
one
initi
gene
target
disrupt
human
bglobin
gene
use
doubl
select
strategi
call
positiveneg
select
vector
employ
gene
target
two
type
insert
vector
ii
replac
vector
insert
vector
linear
restrict
cleavag
within
sequenc
target
target
sequenc
provid
site
recombin
differ
gene
introduc
henc
sequenc
introduc
locat
inner
region
vector
flank
sequenc
involv
recombin
recombin
vector
homolog
cellular
sequenc
produc
duplic
target
sequenc
call
insert
recombin
contrast
linear
replac
vector
two
halv
target
gene
two
end
recombin
occur
within
two
halv
target
gene
replac
portion
endogen
gene
sequenc
introduc
gene
call
replac
recombin
duplic
sequenc
target
gene
becom
disrupt
therefor
approach
use
gene
therapi
strategi
devis
modifi
small
sequenc
target
gene
without
attend
gene
duplicationdisrupt
produc
insert
replac
recombin
approach
call
inout
method
gene
target
consist
follow
two
step
first
step
call
step
target
gene
transfer
use
insert
vector
appropri
target
cell
gene
duplic
ii
second
step
term
step
depend
either
intrachromosom
recombin
introduc
endogen
gene
unequ
sister
chromatid
exchang
homolog
chromosom
recombin
product
interest
chromosom
singl
function
copi
introduc
gene
inout
strategi
test
use
hgprt
hypoxanthineguanin
phosphoribosyltransferas
gene
gene
target
mous
embryon
stein
cell
line
subsequ
success
use
gene
procedur
ideal
gene
therapi
gene
target
strategi
choic
gene
therapi
follow
reason
target
gene
chang
precis
specif
manner
ii
introduc
function
gene
place
context
ie
flank
dna
sequenc
replac
endogen
gene
iii
gene
genom
affect
major
limit
approach
low
frequenc
homolog
recombin
problem
howev
remov
refin
techniqu
feasibl
gene
target
demonstr
number
differ
cell
type
sever
differ
gene
expect
target
therapi
would
becom
feasibl
mani
genet
diseas
near
futur
